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Abstract 
 
 
Genetic interactions of factors that regulate alternative RNA 
splicing in the male germ line of Drosophila 
 
Publication No.________ 
 
Shanzhi Wang, M.S. 
Supervisory Professor: William Mattox, Ph.D. 
 
 
Alternative RNA splicing is a critical process that 
contributes variety to protein functions, and further controls cell 
differentiation and normal development. Although it is known that 
most eukaryotic genes produce multiple transcripts in which splice 
site selection is regulated, how RNA binding proteins cooperate to 
activate and repress specific splice sites is still poorly 
understood. In addition how the regulation of alternative splicing 
affects germ cell development is also not well known. In this study, 
Drosophila Transformer 2 (Tra2) was used as a model to explore both 
the mechanism of its repressive function on its own pre-mRNA 
splicing, and the effect of the splicing regulation on 
spermatogenesis in testis. Half-pint (Hfp), a protein known as 
splicing activator, was identified in an S2 cell-based RNAi screen 
as a co-repressor that functions in combination with Tra2 in the 
	   vi	  
splicing repression of the M1 intron. Its repressive splicing 
function is found to be sequence specific and is dependent on both 
the weak 3’ splice site and an intronic splicing silencer within 
the M1 intron. In addition we found that in vivo, two forms of Hfp 
are expressed in a cell type specific manner. These alternative 
forms differ at their amino terminus affecting the presence of a 
region with four RS dipeptides. Using assays in Drosophila S2 cells, 
we determined that the alternative N terminal domain is necessary 
in repression. This difference is probably due to differential 
localization of the two isoforms in the nucleus and cytoplasm. Our 
in vivo studies show that both Hfp and Tra2 are required for normal 
spermatogenesis and cooperate in repression of M1 splicing in 
spermatocytes. But interestingly, Tra2 and Hfp antagonize each 
other’s function in regulating germline specific alternative 
splicing of Taf1 (TBP associated factor 1). Genetic and cytological 
studies showed that mutants of Hfp and Taf1 both cause similar 
defects in meiosis and spermatogenesis. These results suggest Hfp 
regulates normal spermatogenesis partially through the regulation 
of taf1 splicing. These observations indicate that Hfp regulates 
tra2 and taf1 activity and play an important role in germ cell 
differentiation of male flies. 
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CHAPTER ONE 
General Introduction 
In the original idea of the central dogma (Crick, 1970; Crick, 
1958), RNA was simply thought to be a middle carrier during a flow 
that transferred genetic information from DNA to protein. DNA 
encodes all the information necessary to make final protein 
products, while RNA will be used passively to copy that information 
from DNA and direct protein synthesis. Until 1977 (Berget et al., 
1977) when RNA was discovered to be spliced before entering the 
cytoplasm to direct protein synthesis, people realized that there 
are many regulatory steps at the RNA level during gene expression.  
1. pre-mRNA splicing 
Eukaryotic genes contain both exons and introns. Exons are the 
regions that will be kept in final mRNAs but are split by non-
coding introns. To make coding information intact for future 
protein synthesis, introns will be cut out and other parts will be 
connected together to form complete and useful information. This 
process is called pre-mRNA splicing.  
Although split genes exist in eukaryotic cells, their 
prevalence in the genome is highly diverse across the species. In 
budding yeast, less than 5% of genes have introns and undergo RNA 
splicing. However this percentage can reach more than 90% in the 
human genome (Ares et al., 1999; Neuveglise et al., 2011; Pan et 
al., 2008; Shieh et al., 2011; Wang et al., 2008). 
To get rid of introns from a linear nucleotide chain, splicing 
signals are required to distinguish introns from exons. In general 
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splicing signals are the short sequences residing the exon-intron 
boundaries and within the introns. The 5’ splice site occurs at a 
short conserved consensus sequence with GU as the most 5’ end of 
the intron. Near the opposite end of the intron there are two 
signals: an AG dinucleotide at the most 3' end that is preceded a 
polypyrimidine tract and a loosely conserved branch site sequence 
(Figure 1-1). Briefly, intron splicing takes place in two steps. 
First, the 2’-hydroxyl of an adenosine nucleotide at the branch 
point attacks the phosphate of the guanosine nucleotide at the 5’ 
splice site. This will release a free 5’ exon and a lariat product 
including the rest of the transcript. Second, the free 5’ exon will 
use its 3’-hydroxyl to attack the phosphate of 3’ splice site and 
ligate with the downstream exon, in the meantime the lariat intron 
is released (Figure 1-2). 
RNAs have many important functions including catalysis. The 
“RNA world” hypothesis (Cech, 2011) suggests that RNA itself has 
the potential to function as an enzyme. Actually, the splicing 
reactions of some special introns could be catalyzed just by RNA 
itself (Bonen and Vogel, 2001; Nielsen and Johansen, 2009). However 
in terms of pre-mRNA splicing, proteins and protein-RNA complexes 
are required for RNA splicing to be accomplished correctly. These 
protein factors will recognize the splice sites, recruit other 
factors and form the catalytic complexes by communicating with each 
other to finally complete intron splicing (Wahl et al., 2009).  	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Figure 1-1. Two steps of catalytic reactions of pre-mRNA splicing 
Gray boxes indicate exons and horizontal thin lines indicate 
introns. 5’ and 3’ represent 5’ splice site and 3’ splice site 
within the intron. GU are two starting nucleotides and AG are the 
ending nucleotides of the intron. “A” represents branch point site. 
Two catalytic steps are indicated as numbers. Reactions between 
residue groups are represented by red arrow lines.   	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Figure 1-2. Basic splicing signals for pre-mRNA splicing 
Exons are shown as gray boxes and intron is shown as the horizontal 
line. Polypyrimidine tract is shown as the dash line. GU/AG 
represent the nucleotides in the boundary between the exons and the 
intron.  	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It is known that the U1 small nuclear RNA particle (U1 snRNP) 
recognizes the 5’ splice site, splicing factor 1 (SF1) binds to the 
branch point, and U2 snRNP auxiliary factors (U2AFs) recognize the 
3’ splice site and the polypyrimidine tract. At this point, the 
RNA-protein complex is called E complex. The U2 small nuclear RNA 
particle (U2 snRNP) is then recruited by interacting with U2AF, 
replacing SF1 and base-pairing with the branch point in an ATP-
dependent manner to transform the E complex into A complex. Once a 
stable spliceosome is formed, tri-snRNPs (U4-U5-U6 snRNPs) will 
join in and transform A complex into B complex. After U1 and U4 
snRNPs leave and the complex finishes rearrangement, the whole 
spliceosome becomes active and performs the catalytic function to 
complete splicing in two steps as discussed above (Black, 
2003)(Figure 1-3). 
With the genome becoming more complex, higher eukaryotes 
contain more multi-intron genes (Kim et al., 2008), and RNA 
splicing becomes more flexible to have many choices of determining 
which exons will be included in the final messenger RNAs. Thus this 
process eventually becomes alternative splicing instead of simple 
RNA splicing (or constitutive splicing). Alternative splicing 
patterns include alternative 5’ splice sites, alternative 3’ splice 
sites, exon skipping, the use of mutually exclusive exon and intron 
retention (Figure 1-4). Alternative splicing is thus a highly 
versatile mechanism for producing different mRNA isoforms from a 
single primary transcript.  
Alternative RNA splicing is an essential process for human 
cells to produce various proteins that perform distinct functions 
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in tissue-specific or developmental stage-specific manners. As 
estimated by genome-wide studies, human cells have about 20,000 
genes in their genome, but produce hundreds of thousands of 
distinct proteins. These proteins cannot be encoded in the genome 
by individual genes, so RNA alternative splicing provides a 
wonderful tool to expand the size of the protein pool and increase 
the functional diversity of the cells (Keren et al., 2010). The 
sequencing results with the new RNA-seq technique have shown that 
there are around 100,000 alternative splicing events in human cells 
(Pan et al., 2008). For an example, the Drosophila Dscam gene (Down 
syndrome cell adhesion molecule), which encodes axon guidance 
receptors, can produce 38016 mRNA isoforms by alternative splicing 
to meet its functional requirements in nervous system (Celotto and 
Graveley, 2001; Cooper et al., 2009; Olson et al., 2007). During 
development, alternative splicing plays operative roles in many 
cellular events, such as cell division, cell fate decision and 
tissue maturation (Cooper et al., 2009; Hammond and Wood, 2011). 
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Figure 1-3. Dynamic changes of splicing complex 
Exons are shown as gray boxes and introns are shown as horizontal 
lines. The transformations between the complexes are stated in 
detail in the text. GU and AG represent 5’ splice site and 3’ 
splice site respectively. “A” represents branch point site. U1, U2 
and U4/U5/U6 represent small nuclear RNA particles. SF1 represents 
splicing factor 1. U2AF65 and U2AF35 are U2 snRNP auxillary factors 
65 kDa and 35 kDa. Dashed arrows represent the splicing factors 
that leave from the complexes.  	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Figure 1-4. Alternative RNA splicing patterns 
Diagrams showed different kinds of gene structures. Exons are shown 
as gray boxes and introns are shown as horizontal lines. Boxes with 
different shaded pattern represent alternatively selected exons. 
Splicing patterns are shown as the angled lines above and below the 
gene structures. Thickened line in the last diagram represents the 
retained intron. 	  
 
 
	   10	  
However within complex genomes containing multi-intron genes, 
the limited consensus splice site sequences mentioned above cannot 
alone provide sufficient information to distinguish exons from 
introns. For instance, many exons with tissue specificity contain 
relatively weaker splice sites that are difficult for splicing 
factors to recognize (Berget, 1995). Also pseudo-splice sites 
within the introns will compete for splicing factors with those 
genuine ones (Zhang et al., 2005). Therefore the challenge for 
alternative splicing is to determine which splice sites should be 
used. Since it is critical to accurately define exons and remove 
introns, this process is undoubtedly highly regulated. Fortunately, 
other elements around splice sites are available and hundreds of 
regulators have been found to bind these elements to play either 
positive or negative roles that assist core factors of splicing 
machinery to make the right choices of splice sites.  
 
2. Splicing regulators and cis elements 
Besides core components of splicing complexes, hundreds of 
splicing regulators are required to make sure of the correct 
outcomes of alternative splicing. Generally, based on their roles 
on making decisions, splicing regulators could be regarded as 
either splicing activators or splicing repressors. If the factors 
function to promote recognition of certain splice sites, these 
factors are called splicing activators. On the contrary, if the 
regulators function to make splice sites less recognized, these 
factors are splicing repressors.  
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2.1 Splicing activators and positive regulation 
Splicing activators are factors that can promote recognition 
of splice sites. Among the activators, SR (serine and arginine 
rich) proteins represent a well-studied activator family that 
functions most of the time to promote RNA splicing (Figure 1-5). 
They share some common features such as containing one RS (arginine 
and serine rich) domain in the C terminus, and one or two RRM (RNA 
recognition motif) domains in the N terminus. RS domain usually 
consists of RS-dipeptide repeats instead of randomly distributed 
arginine and serine. It is the target for post-translational 
modifications, and it also mediates protein-protein interactions 
(Wang et al., 1998; Xiao and Manley, 1997). The phosphorylation 
status will affect SR protein activities (Cao et al., 1997; Du et 
al., 1998), and also is responsible for protein shuttling between 
the nucleus and cytoplasm, contributing to their subcellular 
localization (Caceres et al., 1997). The RRM domains are mainly 
responsible for recognizing and binding RNA elements (Bourgeois et 
al., 2004), but in some cases, the RRM is also known to be involved 
in protein-protein interactions (Cho et al., 2011). 
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Figure 1-5. Domain structures of SR splicing factors 
SR splicing family contains RS domains in their carboxyl terminus 
and one or two RRM in the amino terminus. RRM=RNA Recognition 
Motif, RS=arginine serine rich domain. Zn=zinc knuckle. Thin lines 
represent linking regions between the domains.  	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Figure 1-6. Sequences of exonic splicing enhancers 
An exon is shown as the gray box. Thin lines represent the intron 
regions flanking the exon. The yellow box within the exon 
represents an exonic splicing enhancer. Individual recognition 
sequences of splicing factors are shown after the protein names. 	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The RNA elements bound by SR proteins are usually located 
within exons, called exonic splicing enhancer (ESE)(Figure 1-6). 
The enhancers recognized by SR proteins are either purine rich or 
pyrimidine rich (Cavaloc et al., 1999; Graveley, 2000; Schaal and 
Maniatis, 1999). Although different SR proteins each have 
individual binding site preferences, their recognition sites are 
highly degenerate (Liu et al., 1998; Sanford et al., 2009). This 
degeneracy of binding sites might contribute to the functional 
redundancy of SR proteins (Bourgeois et al., 2004; Graveley, 2000). 
It has been found that the binding sites of SR proteins are 
highly enriched in exons compared with introns (Witten and Ule, 
2011). It is believed that binding to the enhancer elements will 
help define the exon and facilitate preliminary spliceosome 
formation. A well-known example is from the alternative splicing of 
doublesex (dsx) pre-mRNA in Drosophila (Heinrichs et al., 1998; 
Inoue et al., 1992; Ryner and Baker, 1991)(Figure 1-7). The dsx 
gene is a key regulator for Drosophila’s somatic sexual 
differentiation. In male flies, dsx pre-mRNA is spliced in a 
default way in which exon 3 is joined to exon 5 with exon 4 being 
skipped (Nagoshi et al., 1988; Salz, 2011). However in females, 
exon 4 is recognized due to the activity of complexes formed on its 
exonic splicing enhancer which contains six 13-nucleuotide repeats 
that bind Transformer (Tra) and Transformer 2 (Tra2) as well as 
Rbp1 and perhaps other SR proteins. Transformer (Tra) is a splicing 
factor expressed only in female flies, while the other factors 
including Tra2 and Rbp1 are non-sex-specific in the Drosophila 
soma. The formation of this complex on the ESE can promote 
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recognition of the weak 3’ splice site of exon 4 by facilitating 
the binding of the U2AF large subunit U2AF50 through interactions 
between the RS domains. Such interactions commit the intron to pre-
spliceosome complex formation (Heinrichs and Baker, 1995; Inoue et 
al., 1992; Tian and Maniatis, 1993; Venables et al., 2012). Similar 
activity was also been observed in the regulation of the female 
specific 5’ splice site of another RNA substrate fruitless within 
the Drosophila nervous system, although the precise mechanism of 
activation has not been defined. (Heinrichs et al., 1998; Venables 
et al., 2012). Also studies of the dsx enhancers showed that the 
effect of each repeat on the splicing is additive instead of 
synergistic. This suggests that multiple SR-enhancer complexes 
increase the probability of a productive interaction between an 
enhancer complex and components of the spliceosome (Hertel and 
Maniatis, 1998). 
The functions of RS domains are not limited to direct 
interactions with pre-spliceosomal proteins such as U2AF. Through 
secondary contacts with RNA sequence near the splice site itself, 
RS domains were also shown to stimulate RNA splicing in a distinct 
manner (Shen et al., 2004). When the RS domains were tethered to 
exon sequences, they were detected to also make contact with the 
branchpoint and promote spliceosome formation. The contact between 
the RS domain and the branchpoint was proposed to be relatively 
stable compared with the transient unstable interactions with other 
RNA sequences. This interaction is thought to facilitate the RNA 
base-paring between the U2 snRNA and pre-mRNA sequences at this 
site, or to prevent the association of inhibitory splicing factors 
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(Shen et al., 2004). The relative in vivo contributions to splicing 
activation of protein-protein interactions involving RS domains and 
those of RS-RNA interactions remains unclear.   
Besides SR proteins, some other factors are also found to 
promote splicing by binding to exonic splicing enhancers. For 
example, YB-1, originally known as a DNA binding transcriptional 
factor, was shown to bind an AC-rich exonic enhancer to promote 
exon v4 recognition during the alternative splicing of CD44 in 
humans (Coulter et al., 1997; Stickeler et al., 2001).  
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Figure 1-7. Alternative splicing of doublesex pre-mRNA 
Splicing factors Transformer (Tra), Transformer 2 (Tra2) and 
another SR protein are assembled on the exonic splicing enhancer of 
exon 4, and help recruit U2AF and recognize the female specific 
weak 3’ splice site. The angled line represents the female specific 
splicing between exon 3 and exon 4. The dashed angled line 
represents the male-type splicing between exon 3 and exon 5. 	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2.2 Splicing repressors and negative regulation 
Splicing repressors are those factors that can inhibit splice 
site recognition and consequently cause exon skipping or intron 
retention in the final mature mRNAs. These factors could repress 
splicing by binding to either exons or introns to interfere with 
early or late steps in the assembly of active splicing complexes. 
To exemplify typical mechanisms that are used by splicing factors 
to repress splicing I will describe several well-studied systems 
below.  
First, splicing repressors can interfere with the primary 
recognition of splicing signals in pre-mRNAs. As discussed above, 
basic splicing signals include 5’ splice site, 3’ splice site, 
polypyrimidine tract and branch point. It was shown that hnRNP A/B 
could bind to an exonic splicing silencer of the vpr exon in HIV-1 
pre-mRNA, nucleate more hnRNP A/B binding upstream of the silencer, 
and repress the exon splicing by competing the activity of U2AF65 
in the upstream polypyrimidine tract (Domsic et al., 2003). Also in 
Drosophila, Sex-lethal (Sxl) represses the male specific exon 
splicing of tra pre-mRNA by binding the polypyrimidine tract of the 
male-specific 3' splice site and blocking the essential splicing 
factor U2AF65 in this site (Valcarcel et al., 1993)(Figure 1-8A). 
Other splicing repressors are known to compete and antagonize 
the functions of splicing activators. For example, In HIV I tat 
exon 2, hnRNP A1 was shown to bind in the exonic spicing silencer 
which is overlapping with another exonic splicing enhancer 
recognized by the splicing activator SC35. It is thought that hnRNP 
A1 represses tat exon 2 inclusion by directly competing out SC35’s 
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activity within the exon. Mutation of the hnRNP A1 binding site in 
the ESS will bring back the efficient splicing that is promoted by 
the binding of SC35 with high affinity (Zahler, 2003)(Figure 1-8B).  
In some cases splicing repressors could form a loop structure 
in the pre-mRNA and exclude the regulated exon from the active 
splicing complex. This kind of regulatory behavior is observed in 
several hnRNP family members. Splicing factors bind the sequences 
in both the upstream and downstream introns flanking the regulated 
exon. Then the proteins will interact with each other, loop out the 
middle exon, and cause the exon skipping. In this way hnRNP A1 
promotes exon skipping in its own pre-mRNA (Black, 2003; Blanchette 
and Chabot, 1999; Rooke et al., 2003). Similar mechanism has been 
suggested to be responsible for the splicing of the c-src N1 exon 
regulated by PTB and hnRNP F/H complex in neuronal cells (Rooke et 
al., 2003)(Figure 1-8C).  
Still another proposed negative mechanism involves the 
interference with specific steps in active spliceosome assembly. 
During spliceosome assembly, new factors will join the complex and 
some factors will leave at the same time. The spliceosome will 
undergo a number of conformation changes between E complex and B 
complex until it becomes catalytically active. Some splicing 
repressors act by disrupting the intermediates in this process 
resulting in the formation of inactive complexes that cannot 
progress to a catalytically active state. For example, RBM5 was 
reported to stall the spliceosome transition after complex A 
formation by blocking the incorporation of U4/U5/U6 tri-snRNP into 
complex A formed on intron 5 and intron 6. In this way, RBM5 
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promotes exon 6 skipping in Fas substrate (Bonnal et al., 
2008)(Figure 1-8D). 
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Figure 1-8. Models of splicing repression 
(A) hnRNP A/B competes with U2AF65 to bind the polypyrimidine tract 
within the 3’ region of the intron, causing 3’ splice site less 
recognized. Sex lethal (Sxl) competes with U2AF65 to associate with 
the 3’ region and prevent more mature splicing complexes from 
forming. (B) The exonic splicing silencer (ESS) overlappes with an 
exonic splicing enhancer. Binding of hnRNP A1 to the ESS will 
compete with SC35, which associates with the same site within the 
exon. (C) hnRNP A1 binds both upstream and downstream of the 
regulated exon. The self-interactions between hnRNP A1 molecules 
loop out the middle exon and cause its splicing repression. (D) 
RBM5 prevents the U4/U5/U6 tri-snRNPs from entering complex A 
formed in intron 5 and intron 6, causing the exon 6 skipping. 	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 3. Position dependent effects of splicing regulators 
 When the hnRNP family factors such as hnRNP A/B, hnRNP A1 and 
PTB were first found to regulate alternative splicing, they were 
identified as splicing repressors (Caputi et al., 1999; Mayeda and 
Krainer, 1992; Singh et al., 1995). Follow-up studies also proved 
time and time again that these factors are mostly involved in the 
splicing repression (Han et al., 2010; Spellman and Smith, 2006). 
SR proteins were initially identified as splicing activators 
(Zahler et al., 1992). And their positive roles on alternative 
splicing are also been verified repeatedly in extensive studies on 
their mechanisms of actions (Bourgeois et al., 2004; Graveley, 
2000). Therefore there is an impression that hnRNP factors can 
generally be regarded as splicing repressors while SR protein 
family should be an important class of splicing activators.  
 However, these observations are not universal and a number of 
exceptions to this general categorization have come to light. In 
some cases it has been found that hnRNP family proteins can promote 
splice site recognition, while SR proteins also have the ability of 
directly repressing the recognition and utilization of specific 
splice sites. 
 One example of this is provided by the hnRNP H protein which 
is known to be a component of splicing enhancer complex binding 
downstream of c-src alternative exon N1. Activation by hnRNP H 
occurs when it forms a heterodimer with hnRNP F to promote the N1 
inclusion in neurons by cooperating with SR proteins and a neural 
specific PTB within an enhancer complex (Chou et al., 1999). An in 
vitro study with a larger intron also showed that hnRNP A can 
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stimulate intron splicing with the cooperation of hnRNP H by 
promoting an intron definition (Martinez-Contreras et al., 2006).  
These exceptional cases could be restricted to particular 
substrates or interacting factors. However, is it possible that a 
general principle hiding behind these observations could explain 
the positive or negative functions performed by the same family of 
splicing regulators? With more and more exceptions discovered, the 
protein binding location is emerging as an important factor in 
determining whether the activation or repression of splicing is 
observed from a given regulator.  
With the development of the technique of RNA-seq, genome-wide 
studies on the alternative splicing by individual regulators has 
become possible. Several important splicing factors in nervous 
system development have been studied in humans and their binding 
targets have been explored at the transcriptome scale (Jensen and 
Darnell, 2008; Ule et al., 2003). In such studies all alternative 
splicing events were identified, and the effects of mutations in 
splicing regulators on the alternative splicing were compared. By 
combining transcriptome sequence with in vivo RNA-protein 
crosslinking and immunoprecipitation it was found that when Fox1/2 
bound the downstream intron of an alternatively spliced exon, it 
could promote the exon’s inclusion, while binding in the upstream 
intron will cause the exon’s skipping. The protein location 
determines its role during the RNA splicing (Zhang et al., 2008). 
Similar effects were also observed in other splicing factors like 
NOVA and some hnRNP family members (Dredge and Darnell, 2003; Ule 
et al., 2006)(Figure 1-9).  
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Models have been proposed to explain how the binding locations 
may be responsible for different splicing consequences (Witten and 
Ule, 2011). When RBPs (RNA binding proteins) bind upstream of the 
alternatively spliced exon, they interfere with the recognition of 
splice signals in the upstream intron and cause the exon’s skipping 
(Chen and Manley, 2009). Fox-1 was shown to repress the splicing of 
exon 4 of the calcitonin/CGRP pre-mRNA by binding a UIF (upstream 
intronic flanking) region, blocking SF1 from binding the branch 
point nearby, and finally preventing E complex formation (Zhou and 
Lou, 2008). When binding to the downstream intron, RBPs help to 
bridge splice sites and promote splicing (Chen and Manley, 2009; 
Licatalosi and Darnell, 2010). In a study of the alternative 
splicing of a cassette exon N30 in NMHC (nonmuscle myosin heavy 
chain) II-B pre-mRNA, another Fox family factor, Fox-3, was found 
to activate N30 inclusion through binding an element within the 
downstream intron (Kim et al., 2011). More interestingly, the 
active function of Fox is dependent on another splicing factor PSF 
(protein-associated splicing factor) in this substrate (Kim et al., 
2011). This suggests that the position-dependent regulation of 
splicing by Fox protein is involved with another layer of 
regulation and might also be determined by the interactions between 
splicing regulators. In some cases, Fox and Nova could regulate the 
same substrate synergistically (Zhang et al., 2010). Fox2 was found 
to bind the 5’ end of intron 9 from Gabrg2 pre-mRNA, while Nova 
bound to the region 3’ of it. It was supposed that by interacting 
with each other, Fox2 and Nova looped out intron 9 and promoted 
exon 9 splicing in humans (Zhang et al., 2010). Even though more 
	   26	  
details of these mechanisms need to be clarified, these studies 
have clearly shown the importance of the binding locations of RNA 
binding proteins in terms of the regulation of alternative 
splicing.  
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Figure 1-9. Position dependence of splicing regulation 
Gene structure is shown with gray boxes and horizontal lines, which 
represent the exons and introns respectively. Middle darker box 
represents a regulated exon. When splicing factors bind downstream 
of the alternatively spliced exon, they will help the exon 
inclusion. While binding upstream of the exon, they will favor the 
exon’s skipping. 	  
 
 
 
	   28	  
4. Splicing repression by SR proteins 
Studies on several pre-mRNAs have revealed the roles for SR 
splicing factors in the negative regulation of alternative 
splicing. An example is from studies on the role of SF2/ASF in the 
splicing of adenovirus IIIa transcript (Figure 1-10). In the early 
stage of infection, SF2 could bind the element within the intron of 
the exon IIIa and represses the recognition of the distal 3’ splice 
site, resulting in the inclusion of a longer exon in early viral 
mRNA (Kanopka et al., 1996; Simard and Chabot, 2002). Another case 
is related with SRp30c, which is shown to bind an intronic splicing 
silencer CE9 of intron 7B in hnRNP A1 pre-mRNA, which causes less 
recognition of the downstream 3’ splice site, and finally in the 
skipping of exon 7B (Simard and Chabot, 2002). In CFTR substrate, 
the SR proteins SRp40 and SF2/ASF form a complex on an intronic 
splicing silencer in intron 9, repress the recognition of upstream 
exon 9 and cause its skipping (Buratti et al., 2007) (Figure 1-14). 
All of these cases share a common feature that SR proteins repress 
RNA splicing by binding to the intronic sequences. 
How do SR proteins repress the RNA splicing? Some SR proteins 
appear to have intrinsic activities that results in the general 
repression of splicing. SRp38, a mammalian specific SR protein, can 
repress pre-mRNA splicing in a cell cycle dependent way (Shin and 
Manley, 2002). Its effect on splicing can be switched from 
repressive into active by its phosphorylation status (Feng et al., 
2008). However SRp38 differs from other SR proteins in that it does 
not act as a general splicing activator. Even in S100 extract, a 
cell free system which is absent of SR proteins but with most other 
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splicing components, SRp38 did not activate splicing as other SR 
proteins did (Feng et al., 2008). Another SR protein SRrp86 was 
shown to repress splicing by interacting and interfering with the 
active functions of other SR proteins such as SC35, ASF/SF2 and 
SRp55 (Barnard et al., 2002). 
Some biochemical properties of these factors also provide 
clues. Unlike other SR proteins, SRp38 contains two RS domains in 
the C terminus. Both of these RS domains perform repressive 
activities. However the repression by RS1 alone is 
dephosphorylation-dependent and this domain has only modest 
activation function. The second RS domain RS2, containing some SK 
dipeptides, displayed a novel second-step repression but without 
dephosphorylation-dependent repression and activation ability (Shin 
et al., 2005). The SRp38 RNA binding domain (RBD) shows more 
similarity with the RRMs of U2AF homology motif family (UHM) rather 
than the canonical RNA binding motifs in other SR proteins. This 
UHM-like RBD has no activation function, but can prevent the RS1 
domain from functioning with positive activity. SRrp86 also contain 
an EK-rich domain which is believed to be responsible for its 
negative activity in RNA splicing (Li et al., 2002). SF2/ASF 
contains two RRMs at its N terminus, as do several other SR 
factors. The second RRM is atypical in sequence and was shown to be 
critical for its repressive activity in the splicing of Adenovirus 
IIIa (Dauksaite and Akusjarvi, 2002). This function seems to depend 
on a conserved “SWQDLKD” motif in the second RRM which was shown in 
tethering experiments to perform an effector function necessary for 
splicing repression (Dauksaite and Akusjarvi, 2002). 
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Figure 1-10. ASF/SF2 represses the distal 3’ splice site 
recognition 
The adenovirus pre-mRNA structure is shown. The angled lines 
represent the splicing patterns. Without SF2, the distal 3’ splice 
site will be recognized. When SF2 is present, it will associate 
with the splicing silencer in the intron and repress the 
recognition of the distal 3’ splice site. E represents the intronic 
element. 	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4.1 Negative auto-regulation of transformer 2 splicing 
Transformer 2 is a Drosophila SR-related protein. As I 
discussed above, it is well-known for its positive regulatory 
function in doublesex (dsx) alternative splicing where it plays an 
essential role for the formation of splicing enhancer complexes and 
for promoting recognition of a weak female specific 3’ splice site. 
Besides its positive function, Tra2 was found to be 
responsible for the retention of the M1 intron in Tra2 transcripts 
produced in growing spermatocytes (Mattox and Baker, 1991; Mattox 
et al., 1996; Mattox et al., 1990). The M1 intron is alternatively 
spliced in the male germline, and the resulting mRNAs encode 
different Tra2 protein isoforms (Figure 1-11). The mature mRNA 
without the M1 intron will use the start codon located at the 
junction of exon 3 and exon 4, therefore it will be translated into 
a 226-amino acid peptides called Tra2-PC. In mRNA where the M1 
intron is retained this start codon is split and a downstream start 
codon within exon 4 has to be used to produce a 179-amino acid 
peptides called Tra2-PE (Mattox et al., 1996). In wild type germ 
cells about 50% of mature mRNAs retain the M1 intron, but in the 
absence of Tra2 function, the intron is efficiently removed from 
germline transcripts and the M1 retaining transcripts were not 
detected. Other introns in the RNA are unaffected by the presence 
or absence of Tra2 function (Mattox and Baker, 1991). Genetic 
studies have shown that Tra2-PC is both required and sufficient for 
M1 retention in the germline (Mattox et al., 1996). Experiments in 
which negative auto-regulation was blocked by the deletion of the 
M1 intron showed that this mechanism served to prevent high-level 
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expression of Tra2 that would block normal spermatogenesis 
(McGuffin et al., 1998). 
In vitro studies have identified several cis-acting elements 
involved in the M1 splicing (Chandler et al., 2003; Qi et al., 
2007). An intronic splicing silencer (ISS) located upstream of the 
branch point was shown to bind Tra2 and was able to mediate the 
repression of intron splicing in vitro when it was inserted into 
the otherwise unregulated ftz intron (Figure 1-12). 
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Figure 1-11. Alternative splicing of transformer 2 pre-mRNA 
Transformer 2 gene structure is shown. The gray boxes represent the 
exons and the horizontal line represents the M1 intron. The 
transcriptional start site is indicated. Two start codons and the 
stop codon are labeled above the exons. The first start codon is 
split by M1 intron. Protein products from two mRNA isoforms are 
shown at the bottom. The mRNA using the first start codon encodes 
Tra2-PC containing 226 amino acids, while the M1 retained mRNA 
encodes Tra2-PE with 179 amino acids. Tra2-PC is able to repress M1 
intron splicing in an auto-regulated manner. 	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Figure 1-12. The intronic splicing silencer of M1 intron 
A section of the tra2 pre-mRNA is shown. The horizontal line 
represents the whole M1 intron. The Black bar represents the 
intronic splicing silencer. Red bars represent the binding repeats 
of Tra2 protein within the ISS. The whole ISS sequence is shown 
below the diagram. Red letters are the CAAGR (R=A/G) repeats 
recognized by Tra2. The blue “A” is the predicted branch point 
site. 
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4.2 Position-dependent splicing repression by SR proteins? 
As I discussed in section 3, it is found that in a genome-wide 
scale, hnRNP family and other RNA binding proteins exhibit 
position-dependent effects on regulating alternative splicing. 
A similar situation has also been observed for SR proteins. 
Taking the adenovirus IIIa pre-mRNA as an example (Kanopka et al., 
1996), when the 3RE element bound by SF2/ASF within the upstream 
intron was moved into the downstream exon, it could be used as an 
splicing enhancer to promote exon splicing by the same SR protein 
ASF/SF2. The ISS element in CFTR intron 9 was also found to exert 
an exonic enhancer function when it was moved to an exon (Buratti 
et al., 2007). A systematic study of this issue is found in work on 
Drosophila transformer 2 (Qi et al., 2007). The ISS element was 
found to contain five CAAGR repeats that bind Tra2 protein and are 
necessary for splicing repression to occur. These repeats are 
located upstream of the branch point but also mediated repression 
from distant intronic positions. This suggests that Tra2-ISS 
complex does not act to simply block the splicing signals, but 
instead represses through other interactions. Interestingly 
Tra2/ISS interactions could exhibit splicing enhancer activity when 
the ISS was inserted into the dsx exon (Shen and Mattox, 2012). 
Further, using an MS2 protein tethering assay (Shen and Mattox, 
2012), Tra2 was found to perform a similar repressive function when 
it was tethered at different positions within the ftz intron, but 
activated splicing when tethered in dsx exon 4 or an exon in a ftz 
RNA substrate. These observations also suggest that the opposite 
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effects were not due to the differences between the ISS and ESE but 
rather due to the binding positions of the protein (Figure 1-13). 
Why does the binding position matter? Why do SR proteins 
prefer to repress splicing when they bind within the introns but 
promote splicing when they bind in exons? So far no example has 
been observed where SR proteins can repress splicing through 
binding to an exon. One explanation depends on "exon definition". 
Considering the ability of SR proteins to promote splice site 
recognition and to recruit U2AF and U1 snRNP to the 3’ and 5’ 
splice sites, SR proteins could be regarded as “exon definers”. 
That is to say that a range of sequences bound by SR proteins will 
be defined as belonging to the exon. More intriguingly, if 
previously defined intron sequences are bound by SR proteins, this 
SR-bound intron part will be “exonized”. 
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Figure 1-13. Position dependent regulation of RNA splicing by Tra2 
(A) When Tra2 is tethered within the ftz intron, it will cause the 
splicing repression and the intron is retained in the final mRNA 
product. (B) When Tra2 is tethered in the female specific exon of 
dsx, it will promote the exon splicing with no intron remained in 
the final mRNAs. MCP-Tra2 is the fusion Tra2 protein with the amino 
acids from MS2 coat protein in the N terminus. MS2 BS is the MS2 
binding sites shown as stem loops. 	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However, this does not explain how “exonizing” of an intron 
would cause splicing repression. For instance, in the case of hnRNP 
A1 pre-mRNA, SRp30c was known to bind the intron upstream of exon 8 
but caused exon 8 skipping instead of inclusion of a longer exon 
inclusion (Simard and Chabot, 2002). Another important factor for 
consideration is the availability of a splice site nearby. Exon 
definition can only make a preliminary decision that the parts SR 
protein bound could be a potential exon. But to complete exon 
definition, the availability of nearby splice sites outside the 
bound region is also necessary. This idea is supported by the 
experiments with CFTR RNAs (Buratti et al., 2007)(Figure 1-14). 
When the people created a novel 5’ splice site downstream of an ISS 
within the intron 9, the resulting spliced products include a new 
exon using a pseudo 3’ splice cite just upstream of the ISS. 
Interestingly the alternative splicing of adenovirus regulated by 
SF2/ASF also suggested a similar mechanism in which the intronic 
part containing the ISS was exonized. And there was a 3’ splice 
site available just upstream of the SR binding sites, consequently 
the final mRNA contained a longer terminal exon 5265K (Kanopka et 
al., 1996)(Figure 1-10). If no splice site is available around the 
SR binding sites, the exon will be skipped or the intron will be 
retained. When Tra2 binds to the ISS element in the M1 intron, it 
helps define the intron part as an exon. However in this case no 3’ 
splice site is present upstream of the ISS within M1, and so the 
direct consequence is the retention of the intron.  
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Figure 1-14. Splicing regulation of CFTR pre-mRNA 
The exons and introns of partial CFTR pre-mRNA are shown as gray 
boxes and horizontal lines. The angled lines represent splicing 
patterns. When SF2 and SRp40 bind to the intron 9, they repressed 
exon 9 splicing. However when a new 5’ splice sites was created 
around their binding sites, a new exon will be defined and included 
by using an upstream cryptic 3’ splice site. 
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 To further test the idea, it would be interesting to see how 
the Tra2-induced splicing pattern will change when a 3’ splice site 
is created upstream of the ISS within the M1 intron. A logical 
prediction is that a smaller intron upstream of the ISS would be 
actively spliced in a manner stimulated by Tra2. Exactly this kind 
of splicing event occurs in Tra2 transcripts from Drosophila 
virilis (Chandler et al., 1997), another Drosophila species that is 
about 60 million years diverged from Drosophila melanogaster. 
Within the vM1 intron (Drosophila virilis M1 intron), as shown in 
figure 1-15, there are several scattered CAAG repeats similar with 
the Tra2 binding sites in M1 intron. A 3’ splice site in this case 
is available just upstream of the CAAG repeats. Consequently vM1 
intron retention could be achieved incompletely with a short 
fragment of vM1 intron being cut off (type B mRNA in figure 1-15). 
Another similar phenomenon is also seen in the splicing regulation 
of a testis-specific exon TLE4 by human Tra2. As shown in figure 1-
16, hnRNP G forms a protein complex with other factors, and help 
recognize the exon T with the weak 5’ splice site but a strong 3’ 
splice site. When the Tra2 level is elevated, it binds to the 
repeated sites upstream of the exon T to form a larger complex. 
Another weak 3’ splice site is located just upstream of the Tra2 
binding sites, resulting in the definition of a longer exon B in 
the presence of Tra2 (Liu et al., 2009). 
Although this model could explain some repressive phenomena 
mediated by SR proteins, we still need to keep in mind that the 
final spliced mRNAs are the products of both positive and negative 
regulations. Even though we saw the splicing repression by SR 
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proteins, it is still possible that other splicing repressors could 
bind to other elements and antagonize the positive functions from 
SR proteins. For example in the regulation of src pre-mRNA 
splicing, SF2/ASF interacts with a negative regulator of splicing 
(NRS) to form a repressive complex upstream of the src exon and 
causes the skipping of the exon (McNally and McNally, 1996). In 
this complex, it is not clear which protein plays a more important 
role on the splicing repression. Interacting partners could be 
another layer of the splicing regulation by SR proteins, just as 
was found in the case of pre-mRNAs regulated by Fox and Nova. 
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Figure 1-15. M1 intron retention in Drosophila virilis 
The M1 intron in Drosophila virilis is also regulated by 
Transformer 2. The Tra2 gene from D. virilis is shown with gray 
boxes and horizontal lines corresponding to the exons and introns 
respectively. Red boxes represent the retained part of the vM1 
intron. Blue bars represent repeated binding sites for the Tra2 
protein. Tra2’s binding to the repeats will repress vM1 intron 
splicing resulting in Type C transcripts but it also facilitate 
utilization of a 3’ splice site available upstream of the binding 
site within the vM1 intron, causing use of a small intron upstream 
of the binding region and production of Type B mRNA. 
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Figure 1-16. TLE4 alternative splicing regulated by hnRNP G and 
Tra2 
Without Tra2 overexpression (A), testis-specific exon T is included 
by hnRNP G complex with other factors recognizing the weak 5’ 
splice site. With Tra2 protein level increased (B), a longer exon 
is included in the testis by Tra2’s binding to the repeats upstream 
of the exon T and recognizing the weak 3’ splice site. Red boxes 
indicate the Tra2 binding sites. 
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5. RNA splicing and germ line development 
 As a critical cellular process, alternative splicing is 
involved in many developmental events (Kalsotra and Cooper, 2011). 
Its disruption can cause developmental defects or diseases 
including cancers (David and Manley, 2010). However how alternative 
splicing regulates germ cell development has not been extensively 
studied and well understood.  
 As a highly organized system, lots of genes are alternatively 
spliced during gametogenesis including those involved in sex 
determination, signal transduction and meiosis. Under normal 
conditions, some genes have multiple spliced isoforms (Liu et al., 
2011) and some of these isoforms are testis- or ovary- specific 
(Chuman et al., 2009; Daniel et al., 2001). There is some evidence 
showing that RNA splicing can be used by germ cells as a way of 
adapting to external conditions (Daniel et al., 2001). For example, 
a mouse gene AchE (acetylcholinesterase) has many variants 
differing in its C terminus produced by the alternative splicing. A 
splicing variant AchE-R was reported to interact with RACK-1 
(receptor of activated protein kinase C) and probably induced 
apoptosis in germ cells under stressful conditions. AchE-R is also 
able to interact with enolase and elevate sperm motility by 
increasing its metabolism (Mor et al., 2008). 
Defects in splicing are also associated with human 
infertility. It is known that splicing defect due to the mutations 
in intron 9 of Wilm’s tumor gene 1 (WT1) can cause decreased 
expression level of SRY and SOX9, which is responsible for Frasier 
syndrome (Schumacher et al., 2008). Also a point mutation in the 
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splice acceptor site of intron 10 of LH receptor gene is reported 
to be responsible for male hypogonadism (Bruysters et al., 2008). 
In Drosophila, a defect in the splicing of Dic61B, a dynein 
intermediate chain gene, can cause abnormal assembly of the sperm 
axonemal complex (Fatima, 2011). Although these studies identified 
specific splicing defects, they put more emphasis on the aspect of 
developmental consequences caused by the impairments of RNA 
splicing. But the regulatory mechanisms of those alternative 
splicing events have not been elucidated. 
Very little is known about how germline alternative splicing 
events are regulated. In only a few studies have critical RNA 
elements and splicing regulators been identified or their 
relationship studied. Human Tra2 has been shown to play roles in 
some of these splicing events. For example, human HIPK3 
(homeodomain interacting protein kinase 3) is localized in PML 
bodies which are related with p53 phosphorylation and apoptosis. 
Its testis-specific splicing was regulated by several well-known 
splicing regulators, such as hnRNP A1, Tra2, ASF/SF2 (Venables et 
al., 2005). ASF/SF2 can form a complex on the testis-specific exon 
while Tra2 and hnRNP A1 will compete with each other to access the 
complex. When Tra2 was hypophosphorylated, it was found to form a 
highly stable complex with SF2 and SRp40, and promote the 
recognition of the weak 5’ splice site of the testis-specific exon. 
In another substrate TLE4 (Transducin Like Enhancer of split 4) 
(Liu et al., 2009), hnRNP G-T and RBMY can bind to a testis-
specific exon which is within intron 6 and normally spliced out 
with the intron in other tissues, then activate its splicing in 
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human testis (Figure 1-16). These studies revealed details of the 
mechanisms of alternative splicing events that happen in testis. 
However their focus is limited to the regulation of alternative 
splicing at the molecular level, with little exploration of how 
important these molecular events are for the normal development of 
germ cells. 
 
5.1 The role of Tra2 in spermatogenesis 
As a splicing regulator that is required for sexual 
differentiation in somatic cells, Tra2’s function in testis is also 
important. Homozygous mutant tra2 flies are sterile and their 
seminal vesicles are empty. Belote showed that Tra2 is required for 
normal spermatogenesis (Belote and Baker, 1983). In tra2 mutants, 
the spermatid heads were not able to elongate, but formed in a 
dense round shape compared with the needle-shaped heads in wild 
type (Belote and Baker, 1983). Some preliminary data suggests that 
mutant primary spermatocytes underwent a delay in entry to meiosis 
but eventually complete normal meiotic divisions (unpublished data, 
Unni and Mattox). It is not known if the delay results from changes 
in the RNA splicing or if it is responsible for infertility.  
Studies on the auto-regulation of Tra2 expression in the 
germline suggest that splicing of the M1 intron is required for 
normal germ cell development (Mattox et al., 1990). As I discussed 
in section 4, this negative autoregulation is believed to limit the 
amount of the functional Tra2 isoform, Tra2-PC. That too much Tra2 
is also toxic for germ cell development was demonstrated by 
deploying a modified system that could escape negative 
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autoregulation and elevate Tra2 level in the meantime (Mattox et 
al., 1996).  
As a well-established model, the study of Tra2 autoregulation 
could be very useful to understand the mechanism of alternative 
splicing in the germline. More importantly, it will be powerful to 
test the effects of splicing events on germ cell development. 
Genetic and cytological analysis can be used to characterize the 
phenotypes and identify molecular targets downstream of Tra2 in 
which RNA splicing may be affected. 
 
6. Goals of this study 
Although SR splicing factors have been studied extensively for 
many years, their ability to repress splicing has remained obscure 
and the mechanisms unclear. As I discussed in section 3, such dual 
roles are not limited to SR proteins but are also observed in some 
hnRNP splicing family members. And it is now clear that the 
positions of regulators binding in relation to splice sites play a 
critical role.  
The Tra2 protein provides an intriguing example of these dual 
roles for its positive role in dsx splicing and the negative role 
in M1 intron retention. What is more interesting is that these 
opposite activities have also been shown to be position dependent. 
The ISS element within M1 intron can mediate Tra2-dependent 
activation or repression depending on whether it is positioned in 
an exon or an intron (Qi et al., 2007; Shen and Mattox, 2012). 
Moreover molecular tethering experiments demonstrate that 
activation and repression functions are mediated by distinct and 
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separable effector domains of the protein (Shen and Mattox, 2012).  
The RS domains of Tra2 are required for the positive splicing 
activity that occurs from exonic positions, while the RRM domain is 
critical for the negative activity observed from intronic sites. 
The RRM domain here is not thought to be used to bind RNA elements 
because Tra2 was tethered on RNA by the MS2 coat protein in these 
experiments. It is possible that the RRM could interact with some 
other proteins to help Tra2 repress M1 intron splicing. Since 
different domains are responsible for its distinct regulatory 
activities, it will be interesting to know what factors are the 
partners of Tra2 and what kind of complexes are formed on the M1 
intron to make intron splicing repressed. To explore this novel 
activity I will use an RNAi screen to identify potential Tra2 co-
repressors and characterize their activities during M1 intron 
splicing. My work reveals that Half pint, a conserved RNA binding 
factor previously described for its role in the positive regulation 
of splicing, plays an essential role in the splicing repression by 
Tra2. 
Negative regulation of splicing by Tra2 is also important 
developmentally in the process of spermatogenesis. However the 
critical targets of Tra2 regulation in the germline have remained 
unclear. Most studies on the role of RNA splicing during 
spermatogenesis focused either on the cytological phenotypes and 
developmental consequences, without elaboration of the mechanism; 
or focused solely on the description of alternative splicing events 
without a clear developmental context. It is important to know how 
RNA splicing in normal conditions of germ cell development. In 
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other words, some detailed questions should be answered like: 
Specifically what critical target genes are alternatively spliced? 
How are these splicing events are regulated? What stages of germ 
cell development are affected by these splicing events? This type 
of approach will provide insights into the role of RNA splicing and 
spermatogenesis, and understand how the regulation of RNA splicing 
itself regulates germ cell development.  
In the studies described here I will make use of the genetic 
approaches available in Drosophila to investigate how Tra2 and Half 
pint affect the alternative splicing of Taf1, a target that plays a 
vital role in spermiogenesis. This analysis provides insights into 
the role that splicing factors play in the development of the 
germline.   
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Chapter Two 
 
An RNAi Screen for Factors Required in Tra2-Dependent 
Repression of pre-mRNA Splicing 
 
Introduction 
 
The mechanisms responsible for repression of splicing by SR 
factors are poorly understood. To shed light on these mechanisms it 
is necessary to identify factors that collaborate with SR factors 
specifically in the repression but not the activation of splicing. 
Transformer 2 provides a classic example of splicing repression by 
an SR splicing regulator. It has been found responsible for the 
retention of M1 intron in its own pre-mRNA in Drosophila male 
germline. Previous studies have focused primarily on cis acting RNA 
sequences involved in repression. Several such elements within the 
M1 intron and the upstream exon are necessary for Tra2-mediated 
splicing repression (Figure 2-1). For example an exonic splicing 
enhancer within exon 3 was shown necessary to obtain maximal M1 
repression but was not sufficient to confer repressions on other 
introns (Chandler et al., 2001). An intronic element close to the 
5’ splice site was shown to function as an intronic splicing 
enhancer (ISE), which promotes efficient basal M1 splicing in the 
soma where repression is not observed in most cell types (Chandler 
et al., 2001). More recently an intronic splicing silencer (ISS) 
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sufficient to confer Tra2 dependent repression on another intron 
was identified (Qi et al., 2007)(Figure 2-2A). This 78 nucleotide 
element is located immediately upstream of the predicted branch 
point of the intron. Within this ISS, there are five repeats of the 
sequence CAAGR that are required for Tra2 binding. In in-vitro 
studies, when the intact ISS was inserted into ftz intron, it was 
found to be sufficient to repress the intron splicing by Tra2 
protein. When these repeats were progressively mutated, both Tra2 
binding and the efficiency of repression were diminished in a 
manner related to the number of repeats affected (Qi et al., 2007).  
The binding of Tra2 was found to inhibit the formation of 
spliceosome complex A. The mechanism of M1 retention by Tra2 could 
be simply explained if Tra2’s binding to the ISS located upstream 
of the branch point physically blocks the access of U2 snRNP to the 
pre-mRNA, an essential step in the formation of this complex  
(Figure 2-2B). However when the ISS was moved upstream away from 
the branch point, about 30 nucleotides distant, it still can 
mediate the splicing repression by Tra2 protein (Qi et al., 2007). 
That suggests instead of passive occupation of the branch point and 
occlusion of U2 snRNP, Tra2 binding with the ISS actually forms a 
functional repressive complex that actively interferes with 
spliceosome assembly. 
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Figure 2-1. Diagram of the regulatory elements within and near M1 
intron 
The section of tra2 pre-mRNA structure is shown with boxes and 
lines, which correspond to exons and intron respectively. Darker 
gray box represents the intronic splicing silencer. The green boxes 
represent the enhancers within exon 3 and M1 intron. An intronic 
splicing enhancer within M1 intron and an exonic enhancer in exon3 
contribute to the recognition of the 5’ splice site. 	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Figure 2-2. A model for M1 retention mediated by Tra2 
(A) The diagram of partial tra2 RNA and ISS element (indicated by 
the thick black bar and five red small bars). The ISS sequence is 
shown below the diagram with the binding repeats labeled with red 
color. The predicted branch point is shown with blue “A”. (B) Tra2 
was thought to occupy the ISS element and prevent U2 snRNP from 
binding to the branch point site, thus repress functional 
spliceosome complex formation. 
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This repressive complex is also suggested to be different from 
another Tra2-dependent complex that activates dsx splicing in the 
soma of Drosophila females. First, Tra2 binding sites are different 
in these two complexes. Tra2 binds directly to a TCAACA element 
within dsx exon 4 (Lynch and Maniatis, 1996), while it binds to 
CAAGR in M1 intron. Second, Transformer (Tra), another key 
component in the splicing complex of dsx exon 4, is not needed in 
M1 retention, because Tra is expressed only in females. When Tra 
was forced expressed in male germline, no effect on M1 splicing was 
observed (Chandler and Mattox, unpublished). Third if ISS was 
replaced by just CAAGR repeats, most of its repressive function was 
lost (Qi et al., 2007), while dsx repeats appeared to function well 
without other elements (Hertel and Maniatis, 1998). Fourth, the 
active and repressive functions of Tra2 are separable. The RS 
domain of the protein has been shown to be the biochemical effector 
region responsible for the activation of splicing from exonic 
positions, but its RRM acts as the effector of its repressive 
activity when bound with an intron, as discussed in Chapter One 
(Shen and Mattox, 2012). These observations suggest that distinct 
factors collaborate with Tra2 during activation and repression of 
splicing and that the repression is likely to depend on one or more 
proteins that have not been identified as in classical studies on 
dsx activation. 
To identify Tra2 co-repressors, we carried out a small-scale 
RNAi screen in S2 cells with a luciferase signal-based M1 splicing 
reporter. This screen identified several factors that are strong 
candidates to function with Tra2 in splicing repression.  
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Materials and Methods 
 
Plasmids and primers 
pM-Luc (M1 reporter) was constructed based on pBluescript SK+ 
vector (pSK+). The promoter from actin 5C was amplified and ligated 
into pSK+ after KpnI and ApaI digestion. The polyadenylation 
element from SV40 was amplified and ligated into pSK+ after SacII 
and SacI digestion. A segment of the tra2 pre-mRNA including the 
entire M1 intron and flanking exon sequences was amplified and 
ligated into pSK+ after ApaI and BamHI digestion. Luciferase coding 
sequence was amplified and ligated into pSK+ after BamHI and XbaI 
digestion. The primers used are listed below: 
 
actin 5c: 5-ATGCCCTACTAGAAGATGTGT, 3-CTCAAACGGTAGTGATATGAA; 
tra2 RNA: 5-TTTCATTTGGATTTGCCCCCT, 3-TTCGCGATCGCGTGATGAACG; 
luciferase cDNA: 5-GAAGACGCCAAAAACATAAAG, 3-TTACACGGCGATCTTTCCGCC; 
SV40 signal: 5-GATCATAATCAGCCATACCAC, 3-GATCCAGACATGATAAGATAC. 
 
3XFlag Tra2-PC was made by inserting a 3XFlag tag into the N 
terminus of the 6XHis Tra2 PC baculovirus expression construct (Qi 
et al., 2007). The DNA fragment encoding the 3XFlag tag was 
synthesized by Integrated DNA Technologies.  
 
Tra2-PC cDNA was amplified from pFastBac 3XFlag Tra2-PC and then 
inserted into pSK+ between the Actin5C promoter and an SV40 
polyadenylation signal (pSK-AS). 
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pftz-Luc was constructed with the similar way of pM-Luc. The only 
difference between these two reporters is that the ftz DNA 
containing the ftz intron and flanking exon sequences, was 
amplified with ftz primers: 
ftz RNA: 5-ATGGACTACTTGGACGTCTACTCG, 3-CTTGATCTGCCTTTCGCTCAG. 
 
RNA interference library 
RNAi library was generously provided by Dr. Eric Wagner. 
Briefly, the library contains cDNAs of CDS fragments of 247 RNA 
binding proteins in Drosophila. The RNAi library is amplified 
first, then 10µL PCR products was used as template to synthesize 
single strand RNA by in vitro transcription (Ambion T7 MEGAscript 
kit). In vitro transcription was performed at 37oC for over night. 
1µL DNAseI (NEB company) was added to each well, incubated at 37oC 
for 20 minutes. Then 100µL dsRNAs were made by mixing equal volume 
of both sense and antisense single strand RNAs in the dsRNA buffer 
(100mM NaCl, 20mM Tris-HCl, pH 8.0, 1mM EDTA) heated at 100oC, 
cooled down at room temperature for at least 30 minutes, and 
finally incubated on ice before use. Both DNA templates from PCR 
reactions and RNA products from in vitro transcription were 
validated by the gel electrophoresis. The library was stored at -
80oC. 
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RNAi screen in S2 cells 
1X107 S2 cells were seeded within 10cm dishes. 30ug total DNA, 
including a Renilla luciferase reporter plasmid as a control for 
transfection efficiency, were transfected with 60µL cellfectin 
(Invitrogen). After 6-7 hours, fresh medium was changed, cells were 
counted and reseeded into 96-well plates with 3X104 cells per well. 
1.5µL dsRNAs were added into the wells and the plates were 
incubated at 28oC for 72 hours. 
 
Luciferase assay 
The medium in each well of RNAi treated cells\ was removed and 20µL 
passive lysis buffer (Dual-Luciferase reporter Assay system from 
Promega) was added. This mixture was incubated at room temperature 
for 15 minutes. Luciferase Assay Reagent II (LAR II) was prepared 
by mixing lyophilized Luciferase Assay Substrate with Luciferase 
Assay Buffer II. 100µL LAR II was added into each well of 96-well 
plates and firefly luciferase activity was measured on a Perkin 
Elmer VICTOR™ X5 Multilabel Plate Reader. Then another 100µL 
Stop&Glo reagent was added, Firefly signal was quenched and Renilla 
luciferase activity was recorded. 
 
Data analysis 
Firefly luciferase activity was divided by Renilla luciferase 
activity for each sample. This ratio was used for further analysis. 
The results of luciferase activities from two independent 
experiments were collected and calculated by MA plot method. 
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Duplicate results for each well were calculated into two 
parameters: M and A. M = log2(N1/N2), which represents the 
reproducibility of the RNAi effect in that well. A = 1/2 X log2(N1 X 
N2), which represents the average value of luciferase activity in 
each well. N1 and N2 represent two values from each time of the 
screen. After each well has its own M and A values, they will be 
normalized by the M and A values from the negative controls, in 
which A value was set as 0(Liu et al., 2007).  
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Results 
1. Validation of a splicing reporter system for the co-repressor 
screen 
To identify factors that contribute to the Tra2-dependent 
repression of M1 splicing we designed a M1 reporter plasmid (pM-
Luc) in which the expression of firefly luciferase depends on the 
splicing of M1 intron (Figure 2-3). The reporter plasmid includes 
part of tra2 gene that contains both the intact M1 intron and the 
flanking sequences from adjoining exon 3 and exon 4. A naturally 
occurring translation initiation codon is split by the M1 intron 
and is positioned as the only initiator that is in-frame with the 
downstream luciferase coding sequence. Cotransfection of Drosophila 
S2 cells with a plasmid expressing the Tra2-PC protein isoform 
results in increasing repression of splicing from this reporter and 
reduced luciferase levels (Figure 2-4). However, neither splicing 
nor luciferase activity from a control reporter (pftz-Luc) 
containing a constitutive intron from the ftz gene was repressed by 
the expression of Tra2-PC.  
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Figure 2-3. Scheme of RNAi screen in S2 cells 
The organization of reporter plasmids used to screen for Tra2 
cofactors in Drosophila S2 cells is shown.  Splicing of the M1 
intron from M1 reporter transcripts leads to expression of firefly 
luciferase (Luc). The exons and M1 intron derive from the 
endogenous Drosophila Tra2 gene. The initiation codon shown is 
naturally split by the intron and is in frame with the luciferase 
coding sequences. Construct of pTra2 has the same promoter and poly 
A signals with the M1 reporter. Cotransfection of both M1 reporter 
and pTra2 into S2 cells will cause minimum luciferase activity 
expression. While knockdown of any Tra2 corepressors in cells by 
its dsRNA will restore the luciferase signal. 	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Figure 2-4. M1 luciferase reporter detects specific repression of 
M1 splicing 
(A) The luciferase activity from M1 reporter but not ftz reporter 
is repressed by the expression of Flag-tagged Tra2-PC in 
cotransfection experiments. Results from luciferase assays (graph) 
and immunoblots probed with anti-Flag antibodies are shown. The 
position of Flag-Tra2 and two nonspecific bands (nc) typically 
observed in such assays as well as molecular weight markers are 
indicated. (B) The effects Tra2-PC on the splicing of transcripts 
from both reporters, as detected by RT-PCR, is also shown. As 
expected, the ratio of amplification products from unspliced (U) to 
those of spliced (S) transcripts deriving from M1 reporter 
increases with higher levels of Tra2-PC.   	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This system was next tested for its response to dsRNA 
knockdown of Tra2 (Figure 2-5). Treatment with tra2 dsRNA restored 
the luciferase activity to nearly the same level as that of the 
reporter only. Treatment with U2AF50 dsRNA on the other hand 
dramatically lowered reporter activity. Since U2AF50 is a core 
basic splicing factor, its decreased level is expected to halt pre-
mRNA splicing. This was indicated in Figure 2-5 by the lower 
luciferase activity that reflects less spliced transcripts. No 
effect was observed when treated with a non-specific control dsRNA 
(Figure 2-5). These results indicate that repression of the M1 
reporter resulting from introduced Tra2-PC could normally respond 
to dsRNA treatments. 
This system was further used to carry out a screen with a 
dsRNA library that targets a group of 247 drosophila proteins 
coding genes with known or potential roles in RNA metabolism (Park 
et al., 2004). The screening layout is shown in Figure 2-6. In each 
plate there are four kinds of controls included. Positive controls 
are the cells transfected with both M1 reporter and Tra2-PC, and 
treated with double stranded tra2 RNA, which is synthesized 
separately in our lab and distinct with the tra2 dsRNA found within 
the library. 
From the screen we identified 15 candidate co-repressors that 
they had stronger effects on M1 reporter luciferase activities than 
the parallel controls treated with tra2 dsRNA. 
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Figure 2-5. M1 luciferase reporter responds to dsRNA treatments 
The luciferase activity from the M1 reporter is restored from Tra2-
PC mediated repression by the treatment of tra2 dsRNA. No effect 
was observed when treated with the control dsRNA (DSRED dsRNA). 
However, even lower luciferase activity was observed when treated 
with U2AF50 dsRNA.  	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Figure 2-6. The layout of RNAi screen in 96 well plates 
The layout of each 96 well plates for RNAi screen is shown. Wells 
in the gray middle part are the wells treated with the dsRNAs 
targeting 247 Drosophila protein-coding genes with RNA binding 
activity. In the wells of left side are the controls without 
transfection (C) and reporter only (R). In the wells of right side 
are the controls of without (R+T2) and with (dstra2) tra2 dsRNA 
treatment.  	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2. Results of RNAi screen 
The RNAi screen was performed in duplicate. The F/R numbers of 
luciferase activities from each well were evaluated using an MA 
plot which relates the reproducibility of the results to the 
magnitude of change in the reporter activity. The final data is 
summarized in the plot shown as Figure 2-7. 
In the plot, each dot represents one gene targeted by the 
dsRNA in the library. In X axis most dots fell around the value 0, 
which suggests most genes’ dsRNAs have no significant effect on the 
M1 intron splicing. However all positive controls were found in the 
very right part of the X axis with the high A values as expected. 
In the Y axis, most dots were also found close to the value 0, 
which suggests most dsRNAs gave reproducible results.  
By comparing with the mean value of positive controls, about 
15 genes were identified that their luciferase activities were 
higher than the positive controls when their protein levels were 
knocked down by corresponding dsRNAs. Among the identified genes is 
tra2 which was blindly detected within the library as a positive 
candidate, supporting the reliability of the screen in detecting 
positives. The total targets were also arranged in their rank order 
of average luciferase activities, as shown in Figure 2-8, that the 
lowest is on the left and the highest on the right.  
 
 
 
 
 
	   67	  
0!
1!
2!
3!
4!
5!
-4! -3! -2! -1! 0! 1! 2!
A= mean(log2 replicate values)!
M=
δ(
log
2 r
ep
lic
ate
 va
lue
)!
Restoration of luciferase level!
Re
pr
od
uc
ibi
lity
 ! Mean of tra2 dsRNA 
positive controls!
	  	  	  
Figure 2-7. The result of RNAi screen 
A library including dsRNAs that are targeting 247 RNA-binding 
protein coding genes of Drosophila was screened in duplicate by 
using the M1 reporter. Data was summarized in an MA plot. 
Candidates were identified with effects similar or greater to that 
observed with four of tra2 dsRNA controls (indicated as the red 
dots). Activity (A) indicates mean value of luciferase activities. 
Reproducibility (M) indicates the difference between log activities 
of the luciferase values from the duplicates. All values were 
normalized with internal control reporter expressing Renilla 
luciferase activity. 
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Figure 2-8. Distribution of library genes in the RNAi screen result 
The finalized luciferase activities from all target genes in the 
library were displayed in the graph with the lowest luciferase 
number on the most left, and the highest on the most right. 
Positive candidates are listed on the right side of the graph. 
Other well-studied splicing factors are indicated by arrows within 
the graph. The red line represents the position of the positive 
control (dsTra2). 
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Among other 14 candidates, 8 of them, including CG4887, 
Hfp/Puf68, SF1, CG6418, Iswi, CG6227, CG14641 and Spf45, are all 
reported having activities in RNA splicing. CG12493 is a double-
stranded RNA binding protein and is known to be required for 
Drosophila spermatogenesis. Vas, Dhh1, CG6418 and CG6227 all 
contain RNA helicase feature.  
 
3. The validation of candidate co-repressors 
To verify the results of the screen, the experiment was 
repeated with the identified candidates and negative controls for 
another two times using both the 96-well and 24-well plate formats. 
The final summarized luciferase results showed that only Hfp/Puf68, 
CG4887 and Spf45 had the most significant effects on the repression 
of M1 intron (Figure 2-9). No luciferase activity or lower 
luciferase activities were observed from the negative control 
targets of the screen. 
Another way to validate the candidates is to test the effect 
of dsRNAs targeting them on the splicing of the M1 reporter. As 
shown in figure 2-10, a majority of reporter transcripts were 
spliced in the reporter only sample. This pattern was reversed and 
unspliced transcripts predominated when a plasmid expressing Tra2-
PC cotransfected. Treatment with dsRNAs of CG4887, Hfp/Puf68 and 
Spf45 respectively decreased unspliced products significantly, as 
shown with RT-PCR and qRT-PCR (Figure 2-11). These results verified 
the results from the luciferase assay and suggest that these 
factors are likely to be co-repressors of Tra2 in M1 intron 
splicing. 
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Figure 2-9. Validation of the positive candidates 
The effects of dsRNAs targeting the positive candidates on the 
luciferase activity are summarized in the graph. Significant change 
in relation to the control of no dsRNA treatment is indicated (*). 
Control dsRNAs from the screen that showed no effect or decreased 
effect on the luciferase activity are shown in dark color.
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Figure 2-10. The effects on splicing patterns of M1 reporter by 
dsRNAs of candidates 
Splicing products from the M1 intron reporter were tested in 
various samples treated with the dsRNAs targeting positive 
candidates. The effects of the dsRNAs on M1 reporter splicing were 
shown in RT-PCR assay. Primer positions are indicated in the 
diagram. The mRNA levels of the candidates in S2 cells were also 
shown on the right side of the images. 	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Figure 2-11. qRT-PCR assay on splicing patterns of M1 reporter by 
candidate dsRNAs 
Splicing products from the M1 intron reporter were tested in 
various samples the same as that used in figure 2-10. The effects 
of the dsRNAs on M1 reporter splicing were shown with quantitative 
RT-PCR. Primer positions are indicated in the diagram.  
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Discussion 
 Using a small-scale RNA interference screen in S2 cells, I 
have identified at least 3 candidate factors that contribute to the 
Tra2-dependent repression of M1 intron splicing. To study the 
regulation of alternative splicing, people usually choose RT-PCR or 
Q-PCR method. However these methods are difficult to adapt to high-
throughput screens due to the multiple manipulations required. On 
the contrary, a screen based on luciferase signal has been 
extensively used and accepted to identify factors involved in a 
particular molecular event. It can give real-time results, which 
avoids middle steps and also saves time. It is also quite 
sensitive, which is very helpful especially for the substrates with 
low splicing efficiency. A key feature of this study is the 
adaption of the luciferase assay to measure a particular 
alternative splicing event. Several previous studies of RNA 
splicing have also used splicing reporters based on luciferase 
activity. However few of them is based on a natural or specific 
splicing event (Gowrishankar and Rao, 2007; Younis et al., 2010). 
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Figure 2-12. A model of interactions between UHM and ULM domains 
within the pre-spliceosome complex 
Splicing factors with UHM and ULM domains recognize basic splicing 
signals within the 3’ region of an intron and communicate with each 
other by the UHM-ULM interactions, leading to pre-spliceosome 
formation and transformation into other splicing complexes. Briefly 
the interaction between U2AF50 and SF1 helps form the E complex. 
Then the interaction between U2AF50 and SF3b155 of U2 snRNP helps 
recruit U2 snRNP into the branch point, thus replace SF1 and 
transform the spliceosome to the A complex. 	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 In this study, I make use of the special start codon split by 
the M1 intron in tra2 pre-mRNA. By fusing luciferase protein coding 
sequences downstream of exon 4 and in frame with this codon, I 
found it is possible to evaluate splicing performance based on 
luciferase activity. Thus this reporter is very compatible with a 
cell-level screen even in a genome wide scale. It can produce 
relatively reliable and quick outcomes telling us which are the 
potential candidates. It can narrow down the scale dramatically 
with less cost of money and time.  
 Several candidates identified in this study are known to play 
roles in alternative splicing events. Among them, Hfp/Puf68, Spf45 
and SF1 share the similarity in that they each contain a U2AF 
homologue motif (UHM) thought important in several steps of RNA 
splicing. This structural domain is distinct, but related to the 
RNA recognition motif found in many RNA binding proteins.  
Functionally UHMs are thought to mediate specific protein-protein 
interactions, most particularly in proteins with ULM (UHM ligand 
motif) sequences. The UHM-ULM interactions play a prominent role in 
the formation of prespliceosomal complexes formed near the 3' 
splice site (Figure 2-12). For example SF1 binds to the sequence at 
the branch point and interacts with U2AF65 bound nearby at the 
polypyrimidine tract through the UHM-ULM contacts (Kielkopf et al., 
2004). Further the UHM-ULM interactions occur between SF1 and 
SF3b155 as well as the large and small subunits of U2AF. The UHM of 
the splicing regulator Spf45 is also reported to be required in the 
alternative splicing of FAS pre-mRNA in vivo. The interaction 
between UHM of Spf45 and ULM of SF3b155, a component of U2 snRNP, 
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competes with the UHM-ULM interaction between U2 snRNP and SF1, 
leading to exon 6 skipping (Corsini et al., 2007). Hfp also contain 
a UHM domain in its C terminus. Since its human orthologue, PUF60 
is known to recognize polypyrimidine tract sequences near the 3’ 
splice site of some introns, it is suggested to function in 
prespliceosome in a similar way as U2AF65 does (Hastings et al., 
2007). A speculative model for the mechanism of M1 intron retention 
is that these candidate proteins, by utilizing their UHM domains, 
might interfere with the interactions between UHM and ULM domains 
in prespliceosome complexes and thus prevent A complex formation 
(Figure 2-13). 
 CG4887 is the Drosophila homologue of RBM5 (RNA binding motif 
protein) in mammalian organisms. Its function in Drosophila has not 
been studied very much, however as a tumor suppressor, RBM5 has 
also been reported to regulate alternative splicing of Fas and c-
FLIP pre-mRNAs, which are the components in apoptosis pathway 
(Bonnal et al., 2008). Common substrates shared by splicing factors 
identified in the screen are summarized in Table 2-1. This suggests 
that the factors identified from the RNAi screen are probably 
functional related and that their shared effects on M1 intron 
splicing is not coincidental.  
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Genes !
Homologous 
gene in 
mammal!
Protein 
Domain!
Known 
targets!
Half-Pint/Puf68! PUF60! UHM! otu, Sxl!
Spf45! SPF45! UHM! Fas, Sxl!
CG4887! RBM5! OCRE! Fas, c-FLIP, Caspase-2!
	  	  
Table 2-1. The targets regulated and shared by positive candidates 
The known targets for each candidate are shown, and common targets 
between the candidates are indicated with circles.  
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Figure 2-13. A model of splicing repression of M1 intron by 
positive candidates 
Tra2 interacts with the positive candidates and form a complex on 
the ISS element. The cofactors with UHM domain will compete with U2 
snRNP to interact with U2AF50 and prevent U2 snRNP from entering 
the complex E.  	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 Other factors identified as possible corepressors correspond 
to helicases. CG6418 is annotated as the Drosophila homologue of 
DDX42 in mammals and Prp5 in yeast. As an RNA helicase it functions 
during the step of U2 snRNP recruitment into spliceosome. CG6227 is 
the homologue of DDX46 in mammals and Prp11 in yeast. It is thought 
to catalyze the conformational change of U2 snRNP and mediate the 
interaction of U1 and U2 snRNPs. Together with other RNA helicase 
identified in this screen, it will be interesting to investigate 
regulatory roles of RNA helicases during alternative splicing. RNA 
helicases are thought to catalyze rearrangement of RNA-RNA 
interactions and RNPs remodeling during RNA splicing, however as 
core splicing factors, whether they have regulatory roles is not 
well studied (Linder and Jankowsky, 2011).  
 
 It is interesting to see that a number of well-known splicing 
factors had no measured effect on the M1 intron splicing when they 
were knocked down, these include SF2 and SC35, as indicated in 
Figure 2-9. In previous study (Qi et al., 2007), Rbp1 was 
previously found to repress M1 intron splicing in vitro and 
observed to bind a sequence within the ISS, but its knockdown 
resulted in a decrease rather than an increase of the luciferase 
activity, which suggests a positive function instead of repression 
on the M1 splicing. Similar effects were observed in both U2AF50 
and U2AF38, which is consistent with our understanding that U2AF 
factors are essential general splicing factors and usually promote 
RNA splicing. B52 is a Drosophila homologue of SRp55 in mammals. It 
is an essential splicing factor for Drosophila development (Kraus 
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and Lis, 1994). B52 can function together with SF2 in the 
regulation of alternative splicing of several substrates (Gabut et 
al., 2007). When B52 was knocked down in our system, luciferase 
activity became dramatically lower, which suggests B52 can actually 
promote M1 intron splicing in normal conditions perhaps due to a 
general role in splicing. Interestingly this result is consistent 
with previous observation from our lab. In an in vitro splicing 
assay, SR protein extract can antagonize Tra2’s repressive function 
on M1 splicing. And the dominant component of SR protein extract is 
B52 (Qi, unpublished results). If and how B52 might antagonize 
Tra2’s activity in M1 splicing is another interesting question to 
explore. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
	   82	  
Chapter Three 
 
Half pint is a Co-Repressor of Transformer 2 
 
Introduction 
Little is known about factors that collaborate with SR 
regulators in the repression of splicing. As described in the 
previous section we have used an RNAi based screening strategy to 
identify factors required for Tra2 dependent repression by the M1 
intron. From a short list of candidates, we identified Half 
Pint/Puf68 (heretofore called Half pint, Hfp). Our focus on Hfp, 
was motivated by the fact that its mammalian homologue PUF60 is 
known to promote the utilization of weak 3’ splice sites and has 
been implicated in the control of alternative splicing. In 
addition, Hfp itself was reported to regulate the alternative 
splicing of several mRNAs in the Drosophila female germline (Van 
Buskirk and Schupbach, 2002). Notably, Hfp and PUF60 (also known as 
FIR) are multifunctional proteins that are known to act as 
transcriptional factors. PUF60 is also called FIR (FBP interacting 
repressor) and negatively regulates c-myc gene expression (Liu et 
al., 2000) through interactions with its far upstream sequence 
elements (FUSE). Independently PUF60 was identified as a splicing 
factor based on its function in recognition of the 3’ splice site 
(Page-McCaw et al., 1999). PUF60 also can function redundantly and 
sometime cooperatively with U2AF65 to regulate weak 3’ splice site 
recognition (Hastings et al., 2007).  
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Hfp also has similarity with proteins in UHM domain family of 
splicing factors (Kielkopf et al., 2004). The UHM domain has been 
found in several splicing factors including U2AF65, U2 snRNP 
subunit SF3b155, SF1 and Spf45. It is structurally like an RNA 
recognition motif but diverges in its RNP2 segment of the RRM. 
Instead of binding RNA, however, UHM domains are functionally 
suggested to be involved in protein-protein interactions. The 
interacting part of UHM domain is known as ULM domain. This domain 
features tyronine residues and is found in U2AF35 and U2 snRNP 
subunit SF3b155. The UHM-ULM domain interactions between several 
factors are thought to promote and stabilize pre-spliceosome 
complex assembly (Kielkopf et al., 2004). 
Here I show that Hfp, which was regarded as a positive 
splicing regulator previously (Hastings et al., 2007; Page-McCaw et 
al., 1999), is able to help Tra2 repress M1 intron splicing in both 
Drosophila S2 cells and testis. Further I show the Hfp gene 
expresses two distinct protein isoforms that differ in their 
ability to repress M1 intron splicing. 
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Materials and Methods 
 
Plasmids and primers 
The M1 luciferase splicing reporter, Tra2-PC vector and ftz 
luciferase reporter are the same as used in Chapter Two. 
 
pftz-ISS-Luc, pftz-mhc-Luc and pftz-ISS-mhc-Luc are all modified 
based on the pftz-Luc reporter. ftz-ISS sequence was amplified from 
pftz120 (Qi et al., 2007) and ligated into pftz-Luc by ApaI and 
XhoI digestion. pftz-mhc-Luc was made by three steps of PCR with 
mhc 3’ splice site sequence fusing into primers: 
ftz RNA forward: 5-ATGGACTACTTGGACGTCTACTCG  
mhc 3’ 1 reverse: 5- CTTGTTTGCAAGGGGATAAGTTCAATGGGTTAGCTAATGAGTTTT; 
mhc 3’ 2 reverse: 5- 
GTCTGACGGGTGCGTTTCGAGTCTTTGCAATCTTGTTTGCAAGGGGATAAG; 
mhc 3’ 3 reverse: 5- 
CTCGAGCTCCAGGGTCTGGTAGCGGGTGTACGTCTGACGGGTGCGTTTCGA. 
pftz-ISS-mhc-Luc was made based on pftz-mhc-Luc with similar steps. 
Only the first step primer is different:  
ISS-mhc 3’ 1 reverse: 5- 
CTTGTTTGCAAGGGGATAAGTTCAAAAATAAGATTATCTTGCGGTTCG. 
 
pFlag-Hfp68 was made in the same way as pTra2-PC, which has an 
actin 5c promoter and SV40 PA signal sequence. Hfp68 cDNA sequence 
was amplified from the plasmid purchased from the Drosophila Genome 
Resource Center. Flag sequences was inserted using a PCR based 
	   85	  
strategy. pFlag-Hfp58 was made in the similar strategy with a 
different start position in the Hfp coding region. 
Hfp68 cDNA forward: 5-
ATGGACTACAAGGATGACGATGACAAGATGGGAAGCAACGACAGAGC;  
Hfp58 cDNA forward: 5-
ATGGACTACAAGGATGACGATGACAAGATGGAGCAGAGCATCAAGATG. 
Hfp cDNA reverse: 5-CTAACCGGACAGATCTCCCTGATC. 
HfpΔUHM reverse: 5-CTAGTCCACCGGCCGCATCAGTC. 
 
Cell culture and transfection. 
Dmel S2 cells was cultured in SFII-900 medium at 28 degree and 
split at regular intervals. When doing transfection, 2X105 cells 
were seeded in 24-well plates. Totally 1.5ug DNA was mixed with 3µL 
cellfectin in 100µL medium. pSK-AS was used as the DNA carrier.  
 
In vitro synthesis of double-stranded RNA 
The procedure for dsRNA synthesis is like described previously 
(Park and Graveley, 2005). Briefly cDNA fragments was amplified and 
inserted into PCR4 vector (invitrogen). M13 reverse and M13 forward 
primers were used to amplify linear DNA template. Then Megascript 
T7, T3 and Sp6 kits (Ambion) were used to produce single-stranded 
RNAs. Single-strand RNAs were mixed in annealing buffer (100mM 
NaCl, 20mM Tris-HCl, pH 8.0, 1mM EDTA), put into 85 degree for 10 
minutes and cool down at room temperature for at least 30 minutes, 
finally incubated on ice for use. 
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tra2 dsRNA primers: forward 5-CGGAATAGAAGTGGATGGTCG, reverse 5- 
TAGTTGCGGAGAGCGTGAAC. 
Hfp3’UTR dsRNA primers: forward 5- TTAGAAGGGGGAGCTATCCG,  
reverse 5- GAATTGGAAACTATAGTTTA. 
Hfp dsRNA primers: forward 5- GGTAGTGCCCACTCTTCCG, reverse 3- 
AAAATGATAGAACAAATGCGGG. 
 
RNA interference assay 
dsRNAs were added directly to the medium of SFII-900 with 4µg/well 
in 24-well plates, 20µg/well in 6-well pates. To get the maximum 
knockdown effect, dsRNA was added two more times in the next 24 and 
48 hours points. 
 
Luciferase assay 
100µL Passive lysis buffer was added into each well of 24-well 
plates. 25µL was used to measure luciferase signal based on the 
manual from the Dual-Luciferase reporter assay system of Promega. 
And luciferase signals are measured on Perkin Elmer VICTOR™ X5 
Multilabel Plate Reader. 
 
RNA immunoprecipitation assay 
1X107cells were seeded in 78cm2 dish. Total 30µg DNA were 
transfected. After 48 hours, cells were washed two times with 1XPBS 
buffer. Then cells were dounced repeatedly in RIP buffer (150mM 
NaCl, 50mM Tris pH 7.5, 5mM EDTA and 0.05% NP-40). Cell lysates 
were pre-cleaned with Sepharose Gammabind beads (Amersham) for one 
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hour. Cell lysates were then incubated with activated beads with or 
without conjugated anti-Hfp antibody at 4 degree for 4 hours. After 
washing beads for 3 times, the whole precipitates were treated with 
Trizol (Invitrogen). RNA isolated from precipitates was analyzed 
with RT-PCR. 
 
Western blot 
Cell was directly lysed in wells. The primary antibody 
concentration is 1:1000 for both anti-hfp antibody and anti-flag 
antibody (Sigma M2 monoclonal antibody). Secondary antibody and the 
ECL system were from GE company. After incubating one hour at room 
temperature, antibodies was washed 10 minutes at room temperature 
for three times. Then exposed to film. 
 
RT-PCR 
1µg RNA was used to do the reverse transcription following the 
manual of Superscript first strand RNA kit from invitrogen.  
 
 
Real-time PCR 
cDNA was synthesized with 1ug RNA total by Superscript first strand 
RNA kit. cDNA was mixed with 2X Syber Green PCR mix from ABI. 
Primer concentration is 0.625 ng/μL. PCR was performed in following 
conditions: 50oC 2 minutes and 95oC 10 minutes, followed by 95oC 15 
seconds and 60oC 1 minute for 40 cycles. 
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S2 cell immunostaining and image analysis 
S2 cells were seeded into 12-well plate with 5X10^5/well 
concentration. Coated covers (BD Biocoat) were put into the wells 
at the mean time.  Cells were allowed to settle down over night. 
Plasmids were transfected next day. After 36-48 hours incubation at 
28oC, cell medium was removed. Cells were washed once with 1XPBS, 
then fixed with 4% paraformaldehyde in PBS at 37oC for 30 minutes. 
After washing with PBS, cells were incubated in PBX (0.2% triton X-
100 in PBS) at room temperature for 10-15 minutes. Blocking with 1% 
BSA at room temperature for one hour, then incubated with first 
antibody (1:200 in 1% BSA) at 4oC over night. Wash cells with PBS 
four times, then incubate in secondary antibody buffer (1:500 in 
1%BSA) at room temperature for 1 hour. After four times washing 
step with PBS, take the coverslips out and put upside down onto the 
slides with mounting medium. Images were taken with Nikon Eclipse 
Ti confocal microscope. Images analyzed for nucleus/cytoplasm 
distribution by Imaris 7.3 after deconvolution by AutoQuant X3. The 
protein nuclear localization was calculated with the signal in 
nucleus divided by that in the whole cell.   
 
Recombinant protein preparation 
Full length Hfp68 cDNA was amplified from the vector AT08368 
purchased from the Drosophila Genomics Resource Center (DGRC). Full 
length U2AF50 cDNA was amplified from whole fly RNA. Both of the 
cDNAs were inserted into pET49b+ vector and protein expression was 
induced by IPTG in BL21. Protein were purified by Glutathione 
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Sepharose (Amersham Pharmacia). 6XHis-Tra2 was expressed and 
purified from baculovirus (Qi et al., 2007). 
 
The gel shift assay 
Recombinant protein was incubated with 100pmol 32p-labeled RNA in 
the binding buffer (25mM Tris pH 7.5, 25mM NaCl, 1mM EDTA, 0.1mg/mL 
tRNA, 0.5mg/mL BSA) at room temperature for 30 minutes. 2µL 
reaction product from total 10µL complex was loaded and separated 
on the polyacrylamide gel in 0.5 X TBE at 4oC for 3 hours. The gel 
was dried and set to exposure. 
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Results 
1. Hfp is required for the Tra2-dependent repression of M1 intron 
splicing in S2 cells 
The effect of Hfp dsRNA on the M1 repression was shown in 
Chapter 2 (figure 2-10). Knockdown of Hfp was found to dramatically 
restore the luciferase activity reduced by overexpression of Tra2-
PC. The effect on luciferase activity is consistent with a de-
repression of M1 splicing when Hfp is knocked down. Testing a 
second dsRNA targeting Hfp, we found similar effects on the 
luciferase activity and verified that levels were significantly 
reduced by the dsRNA, as shown by the immunobloting assay with 
anti-Hfp antibody. Luciferase expression was restored to over 60% 
the level observed in the absence of co-transfected Tra2-PC (Figure 
3-1). The result from western blot showed that levels of Flag-
Tra2PC expressed from the transfected cDNA were unaffected by Hfp 
knockdown indicating that the effect of Hfp knocking-down on M1 
splicing is not due to the indirect effect from a decrease of Tra2 
protein level (Figure 3-2). Taken together the above results 
indicate that Hfp contributes to the repression of M1 splicing in 
S2 cells.  
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Figure 3-1. Luciferase activity is restored by Hfp dsRNA in S2 
cells 
The effect of Hfp dsRNAs on the luciferase activity from S2 cells 
transfected with both M1 reporter and Tra2 cDNA is shown. The graph 
shows percent luciferase activity in relation to that of the cells 
transfected with reporter only. Endogenous Hfp and tubulin protein 
levels from the same samples were analyzed with the western blot 
displayed below. 	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Figure 3-2. The Hfp dsRNA treatment has no effect on Tra2 protein 
level in S2 cells 
S2 cells were transfected with pTra2 and were treated with Hfp 
dsRNA, Tra2 dsRNA and control dsRNA. Western blots detecting the 
protein levels of Flag Tra2 and endogenous Hfp are shown.  A 
monoclonal anti-Hfp antibody was used to detect Hfp level. The M2 
monoclonal anti-Flag antibody was used to detect the transfected 
Flag-Tra2.  	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2. Hfp associates with tra2 transcripts 
The above effects on M1 reporter splicing could potentially 
result from indirect effects of other splicing factors that are 
regulated by Hfp. To test whether M1 RNA transcripts could 
associate with Hfp directly, RNA immunoprecipitation were carried 
out in S2 cell lysates with anti-Hfp antibody. RNA sequences from 
these precipitates were amplified by RT-PCR with primers inside the 
M1 intron and it was found that in comparison to the input signals 
a significant fraction of M1 transcripts are associated with Hfp, 
but no M1 signal was detected in beads only control (Figure 3-3A).  
Notably, the association occured independently of the increased 
expression of Tra2-PC indicating either that basal levels of Tra2-
PC are sufficient to support Hfp binding or that Tra2-PC is not 
required.    
 To further confirm this association and test its specificity, 
M1 reporter was cotransfected with same amounts of ftz reporter and 
another GFP empty vector containing the same promoter and SV40 poly 
A signal (Figure 3-3B). The results showed tra2 M1 transcripts 
could be pulled down with the Hfp antibody. However no amplified 
products from the other two overexpressed transcripts were detected 
in the same precipitate. Together these results suggest that Hfp 
affects splicing of the M1 intron through specific associations 
with tra2 transcripts.   
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Figure 3-3. Hfp associates with tra2 transcripts in S2 cells 
(A) S2 cells were transfected with the M1 reporter, at the same 
time with or without pTra2. RNA immunoprecipitation was carried out 
to pull down the transcripts with anti-Hfp antibody. RT-PCR assay 
detected RNAs precipitated with the Hfp antibody. Primers used are 
indicated in the diagrams. 20% input was used as controls. Expected 
RNAs were labeled with marker number on the right. In= input, 
BO=beads without antibody, BA=beads coupled with antibody. (B) S2 
cells were transfected with three reporters of the same amounts. 
RNA immunoprecipitation experiment was done the same way as in part 
(A). Primers used for RT-PCR were indicated in the diagram. 
Association of Hfp with tra2 RNA is not dependent on Tra2 protein.  	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3. Both ISS and a weak 3’ splice site are required for the 
repression of M1 splicing mediated by Tra2 and Half pint 
Hfp was previously known as a splicing activator that is 
involved in the regulation of 3’ splice site, however as a 
repressor, which elements in M1 RNA will be necessary for its 
negative function? Also it is interesting to know whether the 
sequences within M1 intron previously found to support the binding 
and repression by Tra2 are also sufficient for the repression by 
Hfp. Several elements in tra2 pre-mRNA have been reported to be 
involved in M1 repression (Chandler et al., 2001; Qi et al., 2007). 
Among them, an intronic splicing silencer (ISS) has been identified 
in vitro as a functional target of Tra2-PC as discussed in Chapter 
One and Introduction. In vivo, it has been shown that a weak 3’ 
splice site is critical for M1 retention in testis (Chandler et 
al., 2001). When the natural 3’ splice site of M1 intron was 
substituted with a Drosophila consensus sequence, M1 retention was 
abolished. Replacement with another weak 3’ splice site restored 
the retention to a wild type level. 
As illustrated in figure 3-4, several recombinant luciferase 
reporters containing these different elements were made based on 
the backbone of ftz pre-mRNA which contains a single intron that is 
not normally regulated by Tra2. Notably ftz itself has a strong 3’ 
splice signal and no significant similarity to the ISS. The weak 3’ 
splice site from the intron E of myosin heavy chain gene was used 
to replace the 3’ splice site of ftz intron in the recombinant 
reporters.  
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Figure 3-4. Diagrams of luciferase reporters based on ftz gene 
backbone 
The boxes represent exons and horizontal lines represent introns. 
“Luc” is the luciferase cDNA fused in frame with upstream coding 
sequence. The M1 intron contains a weak 3’ splice site, while ftz 
intron has a strong one. The strong 3’ splice site of ftz intron 
was replaced with another weak 3’ splice site from Mhc intron 5 in 
the reporters of ftz-Mhc-Luc and ftz-ISS-Mhc-Luc. ISS element is 
indicated with a thickened line within M1 intron. It was inserted 
into the introns of ftz-ISS-Luc and ftz-ISS-Mhc-Luc. Intronic 
sequences close to the 3’ splice sites are listed below each 
diagram with red color and italic.	  
	   98	  
To test which elements are sufficient for the M1 repression 
mediated by Hfp and Tra2, the luciferase activities from different 
reporters were measured. As shown in figure 3-5, only when both ISS 
and a weak 3’ splice site were introduced into the ftz intron, the 
reporter (ftz-ISS-Mhc) underwent dose-dependent repression by Tra2-
PC similarly to the M1 reporter. However ftz-based reporters with 
only the ISS or the mhc 3’ splice site failed to show repression in 
response to elevated Tra2-PC. This confirms that both the ISS and a 
weak 3’ splice site are required for the repression mediated by Hfp 
and Tra2. Further we verified that the splicing repression of ftz-
ISS-mhc reporter was reversed by the knockdown of Hfp and Tra2 in a 
similar manner as found with the M1 reporter. But no effect was 
seen with the treatment of the control dsRNA (figure 3-5). Moreover 
the knockdown of Hfp led to a similar reversal of both M1 reporter 
and ftz-ISS-Mhc reporter when tested in the presence of only 
endogenous Tra2 (figure 3-5). To test the possibility that 
endogenous Hfp is present in sufficient levels to drive maximal M1 
repression, a small amount of Tra2-PC, sufficient to cause a small 
increase in the M1 repression, was cotransfected with increasing 
amounts of the 68 kD Half pint isoform (Hfp68) (figure 3-6). The 
increasing amounts of Hfp68 did not produce further repression of 
M1 splicing. This indicates that endogenous Hfp68 levels do not 
limit the degree of M1 repression observed. Taken together the 
above findings indicate that the repressive function of Hfp on 
splicing is specific to some introns that contain certain critical 
elements. In this case, both ISS and a weak 3’ splice site are 
necessary for the splicing repression of M1 intron by Hfp and Tra2. 
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Figure 3-5. Both ISS and a weak 3’ splice site are required for the 
splicing repression by Tra2 and Hfp 
(A) S2 cells were transfected with reporters and different amounts 
of pTra2. The effects of Tra2 on the luciferase activities are 
shown in the graph. Percent luciferase activity is in relation to 
that of the reporter only. Results with significant change are 
indicated (*). Only both ISS and weak 3’ splice site present in the 
intron have the similar effect with that of M1 reporter. (B) The 
knockdown of endogenous Hfp and transfected Tra2 level restored the 
luciferase activities and diminished splicing repression of M1 
intron. No effect was observed when treated with the control dsRNA.  
(C) Reporters were transfected into S2 cells and treated with both 
Hfp dsRNA and tra2 dsRNA. Percent luciferase activity in relation 
to that of untreated group is shown in the graph. Significant 
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change is indicated (*). Only ftz-ISS-Mhc reporter has the similar 
response to the dshfp treatment as the M1 reporter.  	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Figure 3-6. Increasing amounts of Hfp68 cannot repress M1 intron 
splicing 
The luciferase assay carried out after cotransfection with pTra2 
and different amounts of Flag-Hfp68. Repression by endogenous Hfp 
and transfected Tra2-PC was not augmented by increasing the Hfp68 
level. 
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4. Half pint antagonizes U2AF50 activity on M1 intron 
 Initially the binding and functional activity of PUF60, the 
mammalian homologue of Hfp, was found to be at the 3’ splice site 
of a few introns tested. PUF60 could recognize a relatively weak 
polypyrimidine tract that is different from canonical ones 
recognized by U2AF65. Our reporter experiments have suggested that 
Drosophila Hfp also represses splicing through the 3’ region of M1 
intron. To test its relationship with U2AF50 in M1 intron, the 
effects of endogenous Hfp and U2AF50 on M1 splicing were measured 
with M1 reporter in S2 cells. The knockdown of Hfp increased the 
luciferase activity from the M1 splicing reporter by two fold over 
that observed without dsRNA (figure 3-7) which is consistent with 
our previous results. However a parallel knockdown of U2AF50 
resulted in a 2-fold reduction in the activity. Using a splicing 
reporter of the ftz intron, no effect was observed when endogenous 
Hfp was decreased, but the luciferase activity was again reduced 
after the knockdown by U2AF50 dsRNA. These results suggest that 
U2AF50 and Hfp have opposite roles in the regulation of M1 intron 
splicing.  
 Considering both U2AF50 and Hfp are splicing factors 
associating with the polypyrimidine tract, it is possible that 
these two factors compete with each other in this region. To test 
this idea, recombinant Hfp and U2AF50 were expressed and purified 
from bacteria. As shown in a gel shift assay (figure 3-8), U2AF50 
could directly bind to an M1-derived RNA fragment containing both 
the polypyrimidine tract and the 3’SS, but Hfp cannot directly bind 
by itself under this in vitro conditions. Tested with longer RNA 
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substrates, recombinant Hfp only showed weak binding activity with 
the full-length M1 intron (figure 3-9). These results suggest that 
the recombinant Hfp protein probably requires other proteins to 
bind to the M1 intron efficiently.  
 However when Hfp was incubated together with U2AF50 and M1 3’ 
splice site, U2AF50 binding signal was decreased in respond to the 
increasing Hfp concentrations (figure 3-8). However no extra Hfp-
associated signal was observed in these cases, which is consistent 
with previous observation that Hfp itself has a very low affinity 
with the elements in M1 intron. These in vitro binding assays are 
consistent with the findings from splicing reporter assays that 
suggest Hfp antagonizes the effect of U2AF50 in the 3’ part of M1 
intron. 
To test whether any other factors could help Hfp bind M1 
transcript, recombinant Hfp was incubated with RNA fragments in S2 
nuclear extract. The gel shift assays showed similar decreased 
signal of mobility shifted complex with relatively short RNA 
elements in response to elevated recombinant Hfp. However 
recombinant Hfp promoted a more stable protein-RNA complex when 
incubated with the full-length M1 intron in S2 nuclear extract 
(figure 3-10). That suggests that the stable association of Hfp and 
M1 intron need other sequences within the intron, and other factors 
within the S2 nuclear extract might associate with Hfp to form a 
more stable complex within the M1 intron. 
 
 
 
	   105	  
M1-Luc! ftz-Luc!
0!
50!
100!
150!
200!
250!
Re
lat
ive
 L
uc
 a
cti
vit
y (
%
)!
U2af50 dsRNA!
hfp dsRNA! +!
+! –!–!
–! –!
+!
+! +!
+! –!–!
–! –!
+!
+! 	  	  
Figure 3-7. Hfp and U2AF50 have opposite effects on M1 intron 
splicing 
S2 cells were transfected with M1 reporter or ftz reporter. 
Endogenous hfp and U2AF50 were knocked down by their dsRNAs. 
Percent luciferase activity in relation to untreated group is shown 
in the graph. Decreased hfp level had no effect on the luciferase 
activity of ftz reporter but caused significant increase of 
luciferase signal from M1 reporter. Decreasing U2AF50 level reduced 
intron splicing in both reporters.  	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Figure 3-8. Hfp reduced binding affinity of U2AF50 with tra2 RNAs 
(A) U2AF50 and Hfp protein were expressed with GST fusion tag and 
purified from bacteria. Tra2 protein was expressed with His tag and 
purified from baculovirus. Proteins are incubated together with the 
3’ region of tra2 RNA in the binding buffer. The binding complexes 
were separated by the gel shift assay. RNA-protein complex and free 
RNA are indicated by the arrows and arrowheads. Hfp fusion protein 
reduces the amount of U2AF50 associating with RNA target while Tra2 
protein does not. (B) Increasing Hfp amount greatly reduced the 
association of U2AF50 with tra2 3’ region. Triangle represent 
increased Hfp amount within the binding system. 
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Figure 3-9. Hfp protein has a higher affinity with the full-length 
M1 intron 
GST-Hfp was incubated with different lengths of M1 intron fragments 
in in-vitro binding conditions. RNA-protein complex was separated 
with gel shift assay. The fragments were indicated in the diagram 
above the gel images. Hfp-RNA complexes are indicated by the arrows 
and free RNA is labeled by the arrowheads. 	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Figure 3-10. Hfp disrupted complex formed on short tra2 RNA 
fragments 
GST-Hfp was incubated with S2 nuclear extracts and different 
lengths of tra2 RNA substrates. RNA-protein complexes were 
separated with the gel shift assay. Increasing Hfp amount decreased 
complex signal on both RNA substrates of tra2 3’ss and ISS-3’ss. 
When incubated with the whole M1 intron, the signal of the complex 
that S2 nuclear extract formed on the RNA fragment significantly 
increased in a hfp dose-dependent manner.	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5. Half pint is required in vivo for the Tra2-dependent repression 
of M1 intron splicing but not for doublesex splicing   
The splicing repression of M1 intron is most prominently 
observed in the male germline where about 50% of steady state RNA 
contains the M1 intron (Mattox and Baker, 1991) and the repression 
of splicing is entirely dependent on the presence of Tra2 protein. 
To determine if Hfp is also required for M1 repression in vivo we 
dissected testes from wild type and half pint mutant adults.  
Because strong loss of Hfp function results in lethality at earlier 
stages, this analysis was carried out with hypomorphic hfp 
mutations that allow adult survival (Van Buskirk and Schupbach, 
2002). As shown in Figure 3-11 endogenous M1 splicing efficiency 
was significantly increased when half pint function was reduced by 
these mutations. Similar effect was seen in different genetic 
background of hfp mutants. Also dramatic decrease of M1-containing 
mRNAs was seen in the Tra2 mutant. These results demonstrate that 
Hfp is required for the repression of M1 splicing in vivo.   
 Tra2 is also known to activate alternative splice sites when 
it is bound to exonic splicing enhancers. To determine if Hfp is 
generally required for this activation function we tested whether 
female-specific splicing of dsx pre-mRNA is affected in Hfp mutant 
adult flies. RT-PCR was carried out on total RNAs with the primers 
that detect both the male and female specific dsx transcripts as 
diagrammed in Figure 3-11. The results of this experiment, shown in 
Figure 3-11 indicate that neither of two different Hfp loss-of-
function genotypes reduced the selection of the female specific 
splice site that depends on the activation by Tra2. This suggests 
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that Hfp is not generally required for all Tra2-dependent 
alternative splicing events.      
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Figure 3-11. Hfp is required for M1 retention in vivo 
RNA prepared from testis of wild type, Hfp mutant and Tra2 mutant 
flies were used to do RT-PCR. Primer positions are indicated in the 
diagram. Splicing products are shown on the left of the figure. In 
wild type testis, M1 retained mRNA is the major product, while in 
Hfp hypomorphic mutants, the retention level of M1 intron is 
dramatically decreased, which is similar with the effect seen in 
the tra2 mutant. Df(hfp)=Df(3L)Ar14-8. 	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Figure 3-12. Hfp has no effect on the alternative splicing of 
doublesex pre-mRNA 
(A) The alternative splicing of doublesex pre-mRNA is shown in the 
diagram. Three primers were used to amplify both male and female 
products of dsx splicing products and indicated in the diagram. (B) 
Whole fly RNA samples from different genetic background were 
prepared and used in RT-PCR assay. Compared with the Tra2 mutant, 
no male-specific splicing product was observed in Hfp female 
mutants. 	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6. The N-terminus of Hfp is required for its negative regulatory 
function 
Analysis of the Drosophila transcriptome indicate that it 
contains as many as nine alternatively spliced mRNAs from the hfp 
gene (McQuilton et al., 2012)(figure 3-12). These mRNAs are 
predicted to encode either of two protein forms that differ by the 
presence of a 92 amino acid N-terminal sequence. Type A transcripts 
encode a 68 kDa protein (Hfp68) predicted to initiate translation 
in the second exon and consistent with the major Hfp product 
previously reported (Van Buskirk and Schupbach, 2002). All other 
Hfp transcripts contain in frame stop codons a short distance 
downstream of this initiation site. However initiation at a 
downstream start codon found in these transcripts could potentially 
produce a 58 kDa protein.  
To study whether these two isoforms differ in their ability to 
repress M1 splicing, Hfp isoforms were introduced into S2 cells 
with M1 reporter and Tra2-PC. Endogenous Hfp was knocked down by a 
dsRNA specifically targeting the 3’UTR of endogenous Hfp (hfp3’UTR 
dsRNA). Introduced Hfp isoforms escaped the degradation brought by 
the hfp 3’UTR dsRNA since their cDNAs were inserted into the pSK 
backbone which contains a distinct SV40 3’UTR sequence. As shown in 
figure 3-13, endogenous Hfp was dramatically decreased by the 
treatment of hfp3’UTR dsRNA (lane 1 and 2), and the luciferase 
signal correspondingly increased to 150% of the level in the 
control with no dsRNA treatment. Overexpression of Hfp58 (lane 3 
and 4 in figure 3-13) was not able to repress luciferase activity, 
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but introducing Hfp68 (lane 5 and 6 figure 3-13) returned the 
repression to the similar level of that with no Hfp knockdown. This 
phenomenon is also verified by the quantitative RT-PCR experiments 
on mRNAs from S2 cells treated in the same way (figure 3-14). The 
spliced/unspliced ratio of M1 reporter transcripts was observed to 
significantly increase with Hfp knockdown and to be restored after 
the expression of Hfp68 but not Hfp58. These results indicate that 
only Hfp68 is able to repress M1 intron splicing in S2 cells. Since 
the only difference between Hfp68 and Hfp58 lies in the N terminus, 
this suggests that the N terminus is critical for Hfp to function 
in the repression of M1 intron splicing. 
Another interesting part for the Hfp protein is the UHM domain 
in the C terminus. Since it is thought to be involved in protein-
protein interactions critical for splicing, we tested its potential 
role in the M1 retention. A deletion of the entire UHM from Hfp68 
(HfpΔUHM) was made and expressed in S2 cells in the above rescue 
assay. As shown in Figure 3-15, overexpressing HfpΔUHM can strongly 
repress the restored luciferase signals by hfp 3’UTR dsRNA, as 
effectively as did introduced Hfp68. It suggests that the M1 
repression by Hfp is likely independent of UHM domain even though 
it is thought to mediate the interactions between splicing factors.  
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Figure 3-13. Diagram of Hfp mRNA isoforms 
The exon-intron patterns giving rise to various Hfp encoding mRNAs 
as reported in GBrowse feature of flybase.org. The boxes correspond 
to exons, lines to introns. The gray shaded regions are predicted 
to be noncoding parts, the orange regions are predicted to be 
protein coding. Note that only the RA transcript has the potential 
to encode the Hfp68 isoform, all other transcripts are predicted to 
encode Hfp58. The transcription direction is indicated by the 
arrow. 	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Figure 3-14. Hfp58 cannot repress M1 splicing in S2 cells 
(A) S2 cells were transfected with the M1 reporter and constructs 
expressing Flag-Hfp58 or Flag-Hfp68. Endogenous Hfp was knocked 
down by using a dsRNA targeted at its 3'UTR (hfp 3'UTR dsRNA). The 
ability of each Hfp isoform to restore repression was tested by the 
transfections with expression constructs containing the 3' UTR 
sequence from SV40 that are not affected by the dsRNA. Expression 
levels of Hfp58 and Hfp68 were detected by western blot shown below 
the chart. The 92 kD band shown is a non-specific cross-reacting 
protein from the same gel that is used to represent loading. The 
effect on M1 splicing was measured by luciferase assay. (B) 
Quantitative RT-PCR analysis of total cellular RNA from cells 
treated as in (A).  The ratio of spliced/unspliced M1 reporter 
transcripts was determined using the primers as shown in the 
diagram. Significant change compared with the control treated with 
hfp 3’UTR dsRNA only is indicated (*). 	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Figure 3-15. The UHM domain of Hfp has no effect on the regulation 
of M1 splicing 
The role of the conserved C-terminal UHM domain in the splicing 
repression was examined using the same approach as in figure 3-14.  
A construct in which the UHM domain was deleted from Hfp68 
(Hfp∆UHM) was tested for its ability to restore the repression and 
found to be nearly identical to the full-length Hfp68. Results that 
affected significantly from the control treated with hfp-3’UTR 
dsRNA only are indicated (*). 	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7. The Hfp58 isoform that lacks N terminus has different 
subcellular localization with full-length Hfp68 
 To investigate why Hfp58 differs in its function from Hfp68, 
we tested if it has similar access to the pre-mRNA in cells.  
Subcellular localization of both Hfp isoforms were studied in S2 
cells by immunostaining with antibodies to both Hfp and the Flag 
epitope tag. As shown in figure 3-16, transfected Flag-Hfp68 is 
mainly present in the nucleus as indicated by coincidence with DAPI 
signal. The same pattern is seen in the staining of endogenous Hfp 
with anti-hfp antibody in S2 cells where Hfp68 is the primary 
isoform. However Flag-Hfp58 signal was found to divided almost 
equally between the nucleus and cytoplasm. These results showed 
distinct subcellular localization of hfp isoforms in S2 cells that 
is likely to contribute to the observed difference of their 
functions in the regulation of M1 splicing. 
 To quantitate the distribution of these two isoforms we 
analyzed multiple confocal images. Green signal representing Hfp 
isoforms were collected within both the nucleus and the whole cells 
by selecting the 3-dimension space. The percent of Hfp signal in 
the nucleus in related to that in the whole cell was summarized in 
the graph (figure 3-16 C). Nearly half of the Hfp58 was located 
within nucleus while almost all of Hfp68 was contained in nucleus. 
These results showed distinct subcellular localization of hfp 
isoforms in S2 cells that is likely to contribute to the observed 
difference of their functions in the regulation of M1 splicing. 
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Figure 3-16. Hfp isoforms have different subcellular localization 
in S2 cells 
(A) Endogenous Hfp localization (Endo Hfp) detected with anti-hfp 
antibody against its C terminal region is shown in comparison to 
the localization of Flag-Hfp58 and Flag-Hfp68 in cells transfected 
with constructs expressing each form. Anti-Flag antibody was used 
to stain transfected Hfp protein. Both Hfp (green) and DAPI 
immunfluoescent staining (blue) are overlaid on DIC images of the 
same cells in the bottom row. (B) “No transfection” is the control 
that both anti-flag antibody and the secondary antibody were used 
to stain S2 cells with no transfection performed. “Negative 
control” is the control that only the secondary antibody was used 
to stain S2 cells with no transfection performed. (C) The 
subcellular localizations of Hfp isoforms were analyzed by image 
analysis. Flag-Hfp68 and Flag-Hfp58 were transfected into S2 cells 
separately. The percent of signal detected within the nucleus as 
determined by Imaris 7.3, is shown for both Flag-Hfp58 and Flag-
Hfp68.  	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8. Half pint has two isoforms in Drosophila and the expression 
pattern shows sexual difference 
Even though we found two Hfp isoforms differed in their 
behaviors on both the subcellular localization and the ability to 
repress M1 splicing in S2 cells, it is still unclear whether they 
are both naturally expressed in vivo. We tested this in Drosophila 
and in S2 cells by western blot with a monoclonal anti-hfp antibody 
that recognizes an epitope in the C-terminus of both Hfp isoforms. 
Figure 3-17 shows that two bands were detected in wild type flies 
and both are reduced in Hfp deficient mutant. Also both bands are 
increased when corresponding cDNAs of hfp isoforms were introduced 
into S2 cells (figure 3-17). In the overexposed western blot film 
from the experiment in S2 cells (figure 3-17 C), Hfp58 could be 
observed and its level was reduced by the treatment of Hfp dsRNA.  
More interestingly, Hfp68 is the major isoform in male flies, 
but abundant Hfp58 was observed in female flies (figure 3-18). When 
exploring their expression pattern in dissected testis and ovary, 
Hfp68 was found to be the primary isoform in testis while the major 
isoform in ovary is Hfp58. Taken together, these observations 
indicate that both isoforms exist in Drosophila and their 
expression patterns differs between males and females. 
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Figure 3-17. Two Hfp isoforms are expressed in vivo 
(A) Western blot showing the comparison of Hfp expression in 
lysates from a mixture of Drosophila male and female adult flies 
with various genotypes is shown. Both forms are observed in w1118 
adults (carrying two wild type alleles of hfp), but are both 
reduced in hfp13/Df(hfp). (B) Expression of Hfp68 and Hfp58 in w1118 
male (M) and female (F) adult flies is shown as detected by western 
blot.  For comparison lysates from S2 cells (S2) and S2 cells 
transfected with Flag-Hfp58 (F-Hfp58) were loaded on the same gel.   
(C) Both endogenous Hfp isoforms were knocked down by hfp 3’UTR 
dsRNA. The image of western blot from figure 3-14A was over exposed 
(the middle panel). Hfp58 could be seen under the Hfp68 signal. And 
Hfp58 signal showed reduced compared with lane 1 of no dsRNA 
treatment. 
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Figure 3-18. Sexual difference of the expression patterns of Hfp 
isoforms 
(A) Western blot of Hfp isoforms in Drosophila with anti-Hfp 
antibody. Hfp58 is more abundant in female flies and also is the 
dominant form in oocytes compared with Hfp68 in testes. (B) RT-PCR 
of M1 intron splicing in Drosophila. M1 is mostly retained in 
testis compared with that in oocytes. Primer locations are 
indicated in the diagram above the image. 
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Discussion 
 
RNA splicing is a complex process that many positive and 
negative regulators are involved to make a final splicing decision. 
As for SR proteins, they have been studied extensively for its role 
on how to promote pre-mRNA splicing. Here we use Drosophila Tra2 as 
a model to explore how an SR protein negatively regulates 
alternative splicing. The reporter system we used here is designed 
for RNAi screening in S2 cells. Since Tra2 represses M1 intron 
splicing in testis, it is reasonably to think that there are some 
testis specific factors responsible for the M1 retention happening. 
However, our previous result (Qi et al., 2006) clearly showed that 
Tra2 has the potential to repress M1 splicing in somatic cells as 
long as relatively high level of Tra2 was present. That is 
consistent with early observations from our lab that tra2 gene uses 
stronger promoter in male germ cells compared with the somatic 
promoter to get relatively high level of Tra2 and further achieve 
the M1 retention in testis(Mattox et al., 1996).  
 
Hfp was known as a 3’ splice site regulator in mammalian 
system to promote weak 3’ splice site recognition (Valcarcel et 
al., 2007). However in our RNAi screening, it was identified as a 
co-repressor of Tra2 to achieve M1 intron retention. It is 
interesting that two splicing regulators who both were known to 
promote RNA splicing are also required for the repression of M1 
intron splicing. Our previous data has shown that the intronic 
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splicing silencer was sufficient for Tra2 to repress intron 
splicing in vitro. However in S2 cells, we found only ISS itself 
cannot bring the M1 intron retained in the final mRNA but a weak 3’ 
splice site is also required at the same time, which is consistent 
with the observations from our previous in vivo study. When 
intrinsic M1 3’ splice site was changed into a consensus one, M1 
retention was abolished in testis. When the 3’ splice site was 
replaced by another weak one, M1 retention was restored in a 
similar level (Chandler et al., 2001). Here we showed that the M1 
repression by Hfp and Tra2 depends on both ISS and a weak 3’ splice 
site.  
 
There are several studies suggest an exon definition model to 
explain the splicing repression by SR proteins. Our previous 
results also suggested that the M1 intron retention mediated by 
Tra2 could be the result of a transformation from an intron 
definition to an exon definition (Shen and Mattox, 2012). From our 
in vitro studies, it suggested that Hfp could compete with U2AF50’s 
activity in the 3’ region of the M1 intron and form a more stable 
complex with Tra2 and other factors on the whole M1, further define 
the whole intron with flanking exons as a big exon and cause the 
intron retention. It will be interesting to test whether the 
complex formed on the M1 intron contain the components of complex E 
or complex A? 
 
Hfp is originally identified as a transcriptional factor that 
negatively regulate c-myc expression. In our RNAi screen, it is 
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possible that the effect we saw by Hfp knockdown is from down-
regulation of Tra2 level. However our western blot result indicates 
that Tra2 level was not affected. And the result of RNA 
immunoprecipitation assay further showed that Hfp could 
specifically associate with tra2 RNA. These observations lead to 
the conclusion that Hfp contributes to the repression of M1 
splicing through the function as a splicing factor instead of a 
transcriptional factor.  
 
Protein isoforms could have distinct biological functions in 
cellular processes (Cartegni et al., 2006; Markovtsov et al., 
2000). Taking Tra2 as an example, its 179aa isoform was shown 
unable to repress M1 intron splicing in testis, but the other two 
isoforms 264aa and 226aa have the abilities to activate dsx female 
specific splicing in somatic cells and repress M1 splicing in male 
germline (Mattox et al., 1996). Based on the transcriptome 
annotation, the two Hfp protein isoforms are encoded by different 
mRNAs that depend on whether extra exon is included in the first 
intron. However no report has ever shown the presence of these two 
protein isoforms in vivo and any functional differences between 
them. In this study we first showed that both of the Hfp isoforms 
are expressed in S2 cells and Drosophila, even though S2 cell 
contains very low abundance of Hfp58. More interestingly, it is the 
full length Hfp68 instead of Hfp58 that can repress M1 splicing in 
our S2 cell system, which suggests that the N terminus of Hfp68, 
the only difference between the isoforms, is required for Hfp’s 
negative regulatory function. Within the N terminus, there are four 
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serine and arginine (SR) dipeptides that are not present in 
mammalian homologue PUF60 (figure 3-19). It is possible that this 
RS containing part is responsible for the protein localization 
within the cell, even though it shows no similarity with any 
conserved nuclear-localization signal. Although some RS domains of 
SR proteins have shown the ability to locate protein into the 
nucleus (Caceres et al., 1998), the RS-containing N terminus of 
Hfp68 is not comparable with those RS domains with highly repeated 
RS dipeptides. So it is not clear how much role of the four RS 
dipeptides played on the nuclear localization of Hfp68. It will be 
very informative to see whether PUF60 could repress M1 intron 
splicing in flies, or Hfp68 with these RS dipeptides mutations 
could still help Tra2 achieve M1 intron retention.  
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Figure 3-19. The alignment of protein sequences of Hfp68 and Hfp58 
The protein sequences of Hfp isoforms were aligned by using 
MegAlign software. Only the N terminal parts are shown. The 
difference between the isoforms is marked with shaded color. Four 
Arginine-Serine dipeptides within the N terminus are indicated with 
the arrows. 	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Although this unconserved N-terminal domain seems required for 
M1 intron retention, the UHM domain located in the C terminus is 
not needed for this repression to happen. It suggests the 
interaction between U2AFs and U2AF-U2snRNP mediated by UHM domain, 
which is important for activating splicing, is not necessary for 
the splicing repression of M1 intron. This phenomenon also suggests 
that individual domains within Hfp68 are responsible for its 
different behaviors during alternative splicing.   
The difference of subcellular localization between Hfp58 and 
Hfp68 was observed in S2 cells. It helps to explain their 
functional difference on M1 intron splicing. Splicing factors can 
regulate alternative splicing by adjusting their functional level 
accessible to the targets. Some SR proteins are well known in 
shuttling between nucleus and cytoplasm to regulate their nuclear 
concentration, and further regulate RNA splicing (Caceres et al., 
1998; Cazalla et al., 2002). Hfp58 distributes evenly within the 
whole cell compared with Hfp68 highly enriched in nucleus. By this 
way, nuclear concentration of Hfp protein was decreased when 
endogenous Hfp68 was knocked down and Flag-Hfp58 was overexpressed. 
With low concentration of nuclear Hfp protein, its repressive 
function on M1 splicing was compromised, which is clearly shown in 
our luciferase and qRT-PCR assays. However, we still cannot exclude 
the possibility that Hfp58 has the ability to repress M1 intron 
splicing since there is still some within the nucleus. Other 
experiments need to answer whether this RS containing N terminus 
endows splicing activity to half pint protein in vivo. There is 
evidence showing the N terminus of PUF60 is sufficient to repress 
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c-myc transcription as a transcriptional factor, but our 
preliminary data showed the N terminus only of Drosophila Hfp 
cannot repress M1 splicing in S2 cells.  
 
Another interesting question is if Hfp58 expresses in vivo and 
its localization is across the whole cell, what is its role in the 
cytoplasm? So far all of the functions of Hfp are restricted within 
nucleus, both transcription and RNA splicing. Instead of decreasing 
its level in nucleus to regulate RNA splicing as we speculated 
above, is there any possible function on translational regulation 
or protein degradation? Even no cytoplasmic function has been 
reported for Hfp, in vitro interaction studies identified some 
interacting proteins that function in cytoplasm might shed light 
for future directions. 
 
The function division among protein isoforms can be seen 
extensively in vivo. As a bifunctional regulator with two isoforms, 
it will be very interesting to know whether Hfp isoforms have 
functional division in vivo that one isoform is responsible for 
transcriptional regulation while the other one participate in RNA 
splicing. Or both isoforms could be responsible for transcription 
and splicing regulation, but two isoforms exhibit different 
behaviors for particular substrates. For example as a splicing 
factor, one isoform is only for splicing activations and the other 
one is just for repressions. There is report showing that Hfp is 
differently spliced in male and female flies (Hartmann et al., 
2011). Our preliminary data also suggested that these two isoforms 
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are differentially expressed in fly males and females. Considering 
M1 intron is only retained in testis while Tra2 level is similar in 
both testis and ovary, there could be some sex-specific functions 
performed by different Hfp isoforms. Although we found Hfp68 and 
Hfp58 have distinct subcellular localization, no data has ever 
shown the similar difference present in vivo.  
 
To verify these functional roles in vivo, isoform specific 
mutated flies will be extremely helpful. However since one major 
function of Hfp resides in germ cells, there is technical 
difficulty to delete or overexpress hfp isoforms only in male germ 
cells. An improved gal4-UAS tool that could avoid this barrier is 
worth a try to test the ideas (Haley et al., 2010; Ni et al., 
2011). 
 
As a cell-based method to study RNA splicing, a potential 
drawback of the experiments done in S2 cells is the manner of 
transient transfection. With multiple reporters or vectors 
cotransfected and also treatment of dsRNAs, considering the 
efficiency and cell status of each time experiment, the luciferase 
activity could vary a lot from time to time. To avoid this kind of 
fluctuation, stable transfected cell lines should be suggested to 
establish for the future studies. The stable cell lines could 
contain both the M1 reporter and Tra2-PC cDNA. 
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CHAPTER FOUR 
 
The Regulation of Alternative Splicing of Taf1 pre-
mRNA by Half Pint and Tra2 in Drosophila Testis 
 
Introduction 
 
Alternative splicing, as an essential regulatory step of gene 
expression, also plays important roles in germline development. 
Numerous alternative splicing events have been reported during male 
germ line development as discussed in Chapter One. However the 
splicing factors that regulate these events are not known and how 
splicing regulator function is integrated into germ cell 
development is poorly understood.  
The negative autoregulation of M1 splicing by Tra2 is known to 
be important for fertility in male flies. Transgenic flies carrying 
copies of the Tra2 gene in which autoregulation is impossible due 
to a deletion of the M1 intron were found to exhibit dose-dependent 
sterility (McGuffin et al., 1998). The sterile males were found to 
produce mature sperm, but these do not move into seminal vesicle 
indicating that they are immotile. Given that Tra2-PC is 
constitutively expressed from this transgene and is the only 
isoform of Tra2 that is genetically functional in the germline, 
these results suggest that sterility can result from excess Tra2 
activity. Thus a limited level of Tra2 in germline is critical for 
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male fertility and negative autoregulation plays an important role 
in limiting Tra2 expression during spermatogenesis. 
 
 Since Half pint was identified in our RNAi screen as a Tra2 
co-repressor of M1 splicing and has also been shown to affect 
alternative splicing in the female germ line (Van Buskirk and 
Schupbach, 2002), it is interesting to know whether Half pint 
functions together with Tra2 in a common pathway to regulate other 
targets important in spermatogenesis. Both Half pint and Tra2 were 
recently implicated in the regulation of alternative splicing of 
transcripts from the taf1 gene in response to DNA damage and ATR 
signaling in Drosophila cultured cells (Katzenberger et al., 2009). 
 
 Taf1 (TBP associated factor 1) is a transcription factor and a 
subunit of TFIID. Genetic studies suggest it plays an important 
role in cell proliferation and viability in Drosophila. Its pre-
mRNA is spliced into mRNAs encoding four distinct protein isoforms.  
These mRNAs differ from each other by the inclusions of exon 12a 
and exon 13a (figure 4-1). It has been shown that Taf1-2 mRNA is 
highly enriched in the fly testis (Katzenberger et al., 2006). 
Interestingly, several genes encoding other germline specific 
paralogues of TFIID components have been identified in Drosophila 
and are known to share similar mutant phenotypes suggesting an 
important role in the entry into meiosis and for spermiogenesis 
(Hiller et al., 2004). These factors differ from Taf1-2 in that 
their tissue specific expression is determined transcriptionally 
rather than by alternative splicing. Taf1 null mutants are lethal, 
	   137	  
but hypomorphic alleles are sterile in both female and male flies 
(Wassarman et al., 2000). It is reported that Taf1 proteins 
expressed in the testis co-localize with other TFIID components and 
is thought that Taf1 may be required for the integrity of testis 
TFIID complex (Metcalf and Wassarman, 2007). 
 
 In this Chapter I will explore the relationship of Half pint 
and Tra2 in promoting germline development and test how they impact 
germline specific alternative splicing of Taf1 in vivo. 
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Figure 4-1. The diagram of taf1 mRNA isoforms 
The exon-intron pattern of Taf1 pre-mRNA is shown. Gray boxes 
correspond to exons and horizontal lines to introns. Red boxes 
represent exon 12a and blue boxes represent exon 13a. Taf1 mRNA 
isoforms with different exon inclusion patterns are shown with the 
names labeled to the right side of the diagram. 	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Materials and Methods 
Fly stocks 
Stocks used bearing tra2 mutations had the following genotypes: 
w1118/BsY; tra-2B/CyO, w1118/BsY; tra-2PM6/CyO, w1118/BsY; tra-2PM7/CyO, 
w1118/BsY; B1 tra-2/CyO. w1118/BsY; Df(2R)Trix/CyO. 
Hfp mutants used were from the following strain genotypes and were 
obtained from Trudi Shupbach:  w;hfp13/TM6B,Hu. w;hfp9/TM6B,Hu. 
Df(3L)Ar14-8,red[1]/TM2,p(p). hfp3058,recl/TM3,Ser. 
Taf1 mutants were obtained from the Bloomington Drosophila stock 
center: w1118;taf1EP421/TM3,Sb. w1118;taf11 red1 e1/TM3,Sb. y1; taf1R14 
red1 e1/TM2. 
RNAi and GAL4 strains were of the following genotypes and were 
obtained from Drosophila Stock Center: y sev;VAL20-Puf68(y+v+). y 
sev;VAL20-Taf1(y+v+). P[Gal4::VP16-nos.UTR]MVD1. 
The strain w,P[m-w+,bam-Gal4-VP16] was obtained from Dennis 
McKearin (Chen and McKearin, 2003).  
 
Primers for PCR 
Primers used in RT-PCR for Exon12a splicing were: 
Exon 12 forward: 5’-GCATGCCTCCTCATCGAACTC  
Exon 13 reverse: 5’-CATGCCATCCATGGCATCGG 
Primers used in RT-PCR for Exon 13a splicing were:  
Exon 13 forward: 5’-CCGATGCCATGGATGGCATGT 
Exon 14 reverse: 5’-AGGCCCATTATCATCCTGCT 
Primers used in qRT-PCR for Exon 12a splicing were: 
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Exon12a inclusion product: E1212a forward: 5’-
CGTGGAGGAGGTCAAATCCC 
E12a13 reverse: 5’-TCGTCGTCGTCCTCGTCATC 
Exon12a skipping product: E1213 forward: 5’-
CGTGGAGGAGGATCTCCAAT 
E13 reverse: 5’-CGCCCTGATCTAAAATGCTC 
 
Primers used in qRT-PCR for marker gene expression were: 
Twine: forward 5’-ACAATTGGGAAGCCAGGGCGG, 
       reverse 5’-TCGTTGCTCCGCAGGTAGCG 
fzo: forward 5’-TTGGGCTTCCGATCGCCGAG, 
     reverse 5’-AAAGGTGGCAGGGGCGAACA 
aly: forward 5’-GGTCAGCAGTTTTCTGCACG 
     reverse 5’-AATCCGGAAGACTGAGCACG 
can: forward 5’-GGAAATGTCATTGCGTCCCG 
     reverse 5’-GGGTCCTAATGGCTTCGTCG 
bol: forward 5’-GTGAGCAAGGGCTACGGATT 
     reverse 5’-CTTTTTGATGGCCGGTGCAA 
cycA: forward 5’-TTTTGAGCCAAATGGCGGTG 
      reverse 5’-TGGTGTAACTGTCGTCGGTG 
cycB: forward 5’-GGCAGATCCGACAGATGGAG 
      reverse 5’-TGGACATCGTATGGTGCTCG 
RpL32: forward 5’-AGCATACAGGCCCAAGATCG 
       reverse 5’-CTTCTTGAATCCGGTGGGCA 
RT-PCR for genomic verification: 
Hfp mutant: forward 5’-TCCCCACAGTTACTCAAAACCTATC 
            reverse 5’-GTTTGGTGCGAGTTAAAAAGTGTCT 
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Taf1ep421: forward 5’-CGGACATGCTAAGGGTTAATC 
           reverse 5’-CAGCATAGAATCCAGACCCA 
Bam-gal4: forward 5’-AGGTGACCATAAATTGAAAC 
          reverse 5’-GTTCCAGTCTTTCTAGCCTT 
 
 
Real-time PCR 
cDNA was synthesized in 20µL of total volume with 1µg total RNA by 
Superscript first strand RNA kit. 2µL of cDNA from this reaction 
was used as template for PCR amplification. It was mixed with 2X 
Syber Green PCR mix from ABI and supplemented with primers at a 
concentration of 0.625 ng/µL. PCR was performed using the following 
cycle conditions: 50oC 2minutes and 95oC 10 minutes, followed by 
95oC 15 seconds and 60oC 1 minute for 40 cycles. 
 
Fertility test 
Single male flies were cultured with three w1118 virgin females. 
Vials were cleared after flies were kept together for one week and 
offspring were counted at the pupal stage. 
 
Live cyst dissection 
Testis were dissected in the testis dissection buffer (TDB, 0.183M 
KCl, 47mM NaCl, 10mM Tris-Hcl, pH 6.8). Single testes were loaded 
on a slide with 30 µL TDB. The anterior third of the testis was 
peeled open and placed under a coverslip. Extra TDB was soaked 
gradually with Kimwipe under a phase contrast microscope (Leica DMR) 
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and observed until intact cysts were pushed out of the organ.  
Cells within intact cysts were counted. Pictures were taken with a 
Photometrics Quantix camera.  
 
Testis immunostaining 
Testis from wild type flies and other mutant flies were dissected 
in TDB and mounted onto slide in a 30µL (intact testes) or 20µl 
(squashed testes) volume of TDB and covered with a 20mm coverslip. 
Slides were frozen in liquid nitrogen for more than 30 minutes. The 
coverslip was then removed with a razor blade and immediately put 
into fixation buffer (4% formaldehyde, 8% acetic acid, 15% ethanol 
in 1XPBS). After incubating at room temperature for 10-15 minutes, 
slides were placed in 50% acetic acid buffer to wash for one minute, 
followed by three washes in PBS and then incubated for 30 minutes 
in 0.5% PBX (0.5% Triton X-100 in PBS). This was followed by 
blocking with 1% BSA in PBS for 30 minutes at room temperature 
followed and incubation with anti beta-tubulin antibody (1:200 in 
1% BSA) (Developmental Studies Hybridoma Bank) at 4oC over night. 
The next day, slides were incubated with fluorescent secondary 
antibodies (diluted 1:500 in PBX) at room temperature for 2-2.5 
hours after washing three times with PBX. Finally, they were 
stained with PI (1:5000) for 5 minutes at room temperature and 
washed three times. Images were taken with Nikon Eclipse Ti 
confocal microscope. 
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Single fly PCR 
One fly was squashed with 200µL tip containing 50µL SB buffer (10mM 
Tris 8.0, 25mM NaCl, 1mM EDTA and 200ug proteinase K) in 1.5mL 
eppendorf tube. After macerating 20 times, residual SB buffer was 
expelled and the homogenate was incubated at 37oC for 30 minutes and 
then 95oC for 2 minutes. Samples were spun 7500 rpm for 10 minutes 
in an eppendorf microfuge. Finally 2µL of the supernatant was used 
as template for PCR reactions. 
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Results 
1. Half pint and Tra2 have opposite effects on the 
alternative splicing of Taf1 exon 12a 
Alternative splicing of Taf1 pre-mRNA produces four isoforms 
with different inclusion strategies of two alternative spliced 
exons: exon 12a and exon 13a. Previous studies conducted in S2 
cells reported that in response to ATR signaling, Tra2 and Hfp were 
required for the upregulation of mRNAs encoding two Taf1 isoforms: 
Taf1-3, which includes exon 13a, and Taf1-4 which includes both 
exon 12a and exon 13a (Katzenberger et al., 2009). In vivo, the 
same authors found that Taf1 isoforms have distinct expression 
patterns in different tissues. Taf1-2 is highly enriched in the 
testis (Katzenberger et al., 2006). Exon 12a is the only 
alternatively spliced exon included in this mRNA. So I tested 
whether the splicing of this exon is changed in the testes of flies 
with loss of function mutations in tra2 and hfp. Testis RNA from 
several different heteroallelic mutant genotypes was isolated and 
used to do both conventional RT-PCR and as well as real time Q-PCR. 
As shown in figure 4-2, the RT-PCR result showed that more exon 12a 
was included in RNA from tra2b/tra21 loss-of-function mutant testes, 
while it's skipping was increased over wild type controls in Hfp 
mutant testis. Confirming this observation, similar results were 
seen in Q-PCR experiments. Again, more exon 12a inclusion was 
observed in each of three different Tra2 mutant genotypes and less 
exon 12a inclusion was found in both hfp mutant genotypes tested. 
Exon inclusion was increased around 1.5 fold in tra2 mutants but 
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decreased by more than 2 fold in Hfp mutants. These results 
indicate that the Tra2 protein normally functions to inhibit 
inclusion of this exon while Hfp acts to favor inclusion. Thus, 
unlike the M1 intron where Tra2 and Hfp collaborate to repress 
splicing, the effect of Hfp on exon 12a splicing is opposite to 
that of Tra2.   
Alternative splicing of exon 13a was also tested, but no 
dramatic effect on its inclusion was seen in RNA from either tra2 
or Hfp mutant testes (figure 4-2). It should be noted that these 
effects of Hfp and Tra2 on splicing in the germline are distinct 
from those observed earlier in studies on Drosophila S2 cells 
subject to genotoxic stress (Katzenberger et al., 2009). Thus these 
factors have different effects on splicing during normal germline 
development. 
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Figure 4-2. Hfp and Tra2 have opposite effect on exon 12a splicing 
in Drosophila testis 
(A) RNA from testis of Drosophila with various genotypes was used 
for RT-PCR. Primers positions are indicated in the diagram. More 
exon 12a inclusion was observed in the testis of tra2 mutant flies, 
while the same exon was reduced in Hfp mutants. (B) Additional 
genotypes were analyzed by quantitative RT-PCR. The ratio of 
transcripts with and without exon 12a in the control strain w1118 was 
set at 1.0 and results from other strains and used to normalize 
results in this comparison. In three different tra2 mutants, the 
transcripts with exon 12a inclusion were consistently increased, 
while a 2-fold decrease was observed in Hfp mutants. The Df(2R)Trix 
chromosome is indicated as Df(tra2). The Df(3L)Ar14-8 chromosome is 
indicated as Df(hfp). 	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2. Overexpression of Tra2 in vivo does not cause more exon 
12a exclusion 
As M1 splicing of Tra2 transcripts in the germline is 
increased in Hfp mutants (figure 4-3A) these mutants are expected 
to have higher levels of Tra2 activity in the form of increased 
Tra2-PC. Therefore the opposite effects of Hfp and Tra2 on Taf1 
splicing might be explained in either of two ways illustrated in 
figure 4-3B. One possibility is that Hfp and Tra2 function in 
parallel paths to independently regulate exon 12a splicing (figure 
4-3B1). Another possibility is that the effect of Hfp on exon 12a 
is actually a secondary consequence of its effect on M1 repression 
and Tra2 activity (figure 4-3B2). Without Hfp dependent negative 
feedback, excess Tra2 is expected and this could lead to the 
effects opposite to those of loss-of-function Tra2 mutants. To 
distinguish these two possibilities, exon 12a inclusion was tested 
after increasing the expression of Tra2-PC in vivo. 
We used two approaches to increase Tra2 level in male flies. 
In the first method we attempted to overexpress Tra2 specifically 
in primary spermatocytes using Gal4-UAS system. Tra2 expression was 
driven from a UAS-mycTra2 transgene produced previously in our 
laboratory and used to study overexpression of Tra2 in the soma (Qi 
et al., 2006). GAL4 expression was obtained using the Bam-GAL4 
transgene known to be active specifically in pre-meiotic 
spermatogonia and spermatocytes. However, based on RT-PCR 
experiments, we observed that this system produced only a very 
small effect on overall Tra2 mRNA levels in the testis (figure 4-
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4B). As shown in figure 4-4A, no effects on taf1 exon 12a inclusion 
were seen in qRT-PCR experiments with Gal4-driven expression of 
either Tra2 or Hfp.  
Because the above results were inconclusive we further 
explored this splicing regulation working model using several fly 
strains that contain two copies of a tra2 transgene with the M1 
intron has been deleted. As discussed in the Introduction, Tra2 
keeps its expression level constant in testis by negatively 
autoregulating M1 intron splicing (figure 4-5A). This M1 intron 
deleted transgene is expected to escape negative regulation by Hfp 
and thus, if Hfp affects Taf1 splicing through its effects on M1, 
the presence of the transgene should rescue such effects (figure 4-
5B,C). Exon 12a inclusion was tested by Q-PCR (figure 4-6). However 
no difference was observed between the transgenic flies with 
constitutive Tra2 expression and controls. In this case RT-PCR 
experiments confirmed that the tra2 mRNA amount were increased 
within Tra2 overexpression testis. The increased level was 
comparable to that in Hfp mutant testis (see figure 3-12). This 
result suggests that the effect of exon 12a splicing we saw in Hfp 
mutant is not due to the epistasis regulation of tra2 splicing. Hfp 
functions in parallel with Tra2 on the exon 12a. 
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Figure 4-3. Models of RNA splicing regulated by Hfp and Tra2 in the 
male germline 
(A) Hfp and Tra2 are both required to repress M1 intron splicing 
from tra2 pre-mRNA. Hfp and Tra2 function oppositely in the 
inclusion of exon 12a splicing in Taf1 mRNA. (B) Two possibilities 
for the regulation of exon 12a mediated by both Hfp and Tra2. 1) 
Hfp indirectly affects exon inclusion by negatively regulating Tra2 
splicing, and expression of functional Tra2 protein. 2) Hfp and 
Tra2 function in parallel to control inclusion of the exon.	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Figure 4-4. The Bam-GAL4 drivert failed to increase expression of 
mRNAs from UAS-mycTra2 or UAS-Hfp and had no effect on exon 12a 
splicing (A) Testis RNA from both the wild type control w1118 and 
other control and experimental genotypes was examined quantitative 
RT-PCR. GAL4-UAS driven expression of Tra2 and Hfp had no effect on 
exon 12a splicing, compared with Bam-Gal4 control. Error bars 
represent the standard deviations of the means. (B) Further RT-PCR 
analysis of RNA from these genotypes indicated that neither Hfp nor 
Tra2 mRNA levels were significantly increased by the GAL4 and UAS 
transgenes.  
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Figure 4-5. Mutated tra2 gene escapes its negative auto-regulation 
(A) The diagram showing two mRNA isoforms that are produced by the 
alternative splicing of tra2 RNA in the male germline. One of the 
isoforms encodes a functional Tra2 protein with 226 amino acids 
(also called Tra2-PC). (B) The diagram illustrating how an 
artificial transgene without the M1 intron can escape negative 
regulation and keep the Tra2-226 level constantly high in vivo.  	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Figure 4-6. Increasing Tra2 in testis does not affect exon 12a 
splicing  
Testis RNA from both w1118 and various genotypes was used to do 
quantitative RT-PCR (graph above) and regular RT-PCR (gel image 
below) in parallel. Both 34-2/34-2 (tra2+ background) and 41.7/6-1 
(insertion in the second chromosome that is balanced with CyO 
balancer) are transgenic strains carrying two tra2 transgenes 
lacking the M1 intron. Although Tra2 mRNA levels were increased, no 
effect on exon 12a was observed in these two genotypes as compared 
with wild type (w1118) and tra2b/Cyo controls. Note that the P value 
of 41.7/6-1 in relation to tra2b/Cyo control is 0.736. Tra2 mRNA 
levels are shown to be increased in the RT-PCR analysis below the 
graph. Error bars represent the standard deviations of the means. 
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3. Hfp and Taf1 are both required for male fertility and the 
formation of motile sperm 
Given its role in Taf1 splicing we next examined whether Hfp 
is required for normal spermatogenesis. As shown in figure 4-7, two 
of the Hfp mutant genotypes tested displayed significant male 
sterility. In addition, among males that displayed fertility there 
was a dramatic decrease in the number of offspring produced. To 
determine if sterility was due to an absence of mature sperm we 
examined the seminal vesicles of sterile Hfp mutants and compared 
them to wild type. The empty seminal vesicles of the mutants 
indicate a failure to produce mature motile sperm. We conclude that, 
like Tra2, Hfp plays an important role in spermatogenesis. 
 Because Taf1-2 is highly enriched in the male germline and is 
alternatively spliced under the control of both Hfp and Tra2, we 
next examined whether Taf1 expression is similarly required for 
male fertility. To address this issue we first examined available 
mutations in Taf1. Strong loss-of-function mutations in Taf1 are 
lethal, and at least one available viable hypomorphic genotype 
tested produced only fertile males (table 4-1). We therefore turned 
to RNA interference to produce a tissue specific knockdown of Taf1 
function. We took advantage of the Gal4-UAS system to drive Taf1 
dsRNA expression specifically in male germ cells. Transgenic flies 
bearing a construct that produces Taf1 dsRNA from the VAL20 vector 
were used in these experiments (Haley et al., 2010). This vector is 
driven by the GAL4 system but is reported to be effective in the 
male germline and therefore we expected to avoid the low-expression 
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issues encountered in earlier with germline specific expression 
experiments. The Gal4 transcriptional activity is driven by Bam 
promoter which starts transcription in transit amplifying 
spermatogonia (Chen and McKearin, 2003) which corresponds with the 
earliest stages where Taf1 is detected (Metcalf and Wassarman, 
2007). Using this approach we observed that taf1-RNAi males are 
completely sterile (figure 4-7).   
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Figure 4-7. Fertility test of both Hfp and Taf1 mutant males 
(A) Offspring from males with various genotypes crossed with wild 
type virgins were counted and summarized in the graph. The males 
producing any offspring are defined as fertile. Numbers above the 
column represent fertile males versus total tested males. Males 
from both Hfp mutants showed dramatically decreased fertility and 
complete sterility was observed in taf1 RNAi mutant males. Error 
bars represent the standard deviations of the means. (B) Expression 
level in taf1 mRNA in RNAi flies. RT-PCR assays were done with 
testis RNA from various genotypes. Flies carrying both Bam-Gal4 and 
the taf1 dsRNA constructs are expected to express taf1 dsRNA in the 
male germline. Flies carrying Bam-Gal4 and taf1EP421 are expected to 
have increased Taf1 pre-mRNA synthesis as the UAS elements are 
located immediately upstream of the endogenous Taf1 gene, as 
illustrated in (C). 	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Males ! No. fertile/No. tested!
No. of progeny 
per fertile male!
w1118! 10/10! 79.4 ± 15.1!
taf1R14/taf1EP421! 9/10! 81 ± 10.45!
taf11/taf1EP421! lethal!
	  	  
Table 4-1. Fertility tests of Taf1 mutants 
No effect on the fertility of taf1R14/taf1EP421 mutant was observed. 
The other mutant taf11/taf1EP421 is lethal. 	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4. Half pint is required for a normal number of transit 
amplifying mitotic divisions in spermatogonia 
Spermatogenesis in Drosophila starts with production of gonial 
cells from germline stem cells located at the anterior tip of the 
testis. These gonial cells will divide four times in synchrony with 
incomplete cytokinesis to form a cyst of 16 interconnected cells.  
The cyst is surrounded by two somatic cyst cells. These divisions 
are referred to as transit amplifying mitotic divisions because 
they amplify the number of products from the stem cell. Once the 
spermatogonia number reaches 16, they will stop dividing and start 
to grow. By the time spermatocytes enter meiosis they have 
increased in volume by 25 times (Insco et al., 2009). The whole 
process is illustrated in figure 4-8.  
Examination of early spermatogenesis revealed that in each of 
several half pint mutant genotypes (hfp13/hfp9 see figure 4-9, 
hfp13/hfp3058, hfp13/Df(3L)Ar14-8 data not shown) the majority of 
spermatocyte cysts produced 8 rather than the usual 16 germ cells. 
This suggests that, like in the female germline, Hfp is required to 
promote a fourth mitotic cell division. Examination of the 
morphology in these cysts indicates that the cells within them have 
features distinctive of spermatocytes (large and round nuclei and 
prominent nucleoli, no sign of dividing). Moreover in a manner 
similar to 16 cell cysts, they grow dramatically after mitosis is 
completed and are able to enter meiosis upon completion of the 
growth phase (see below). These results indicate that Hfp is 
required to determine the number of spermatocytes/cyst but are not 
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required for other visible pre-meiotic events. We also examined 
spermatocytes from tra2 mutants, but consistent with previous 
reports, the loss of function for this gene had no visible effect 
the number of mitotic divisions or on spermatogenesis prior to 
meiosis (figure 4-10).  
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Figure 4-8. Illustration of spermatogenesis in Drosophila 
Germ cells within the adult testis are illustrated on the left. The 
yellow circle at the tip represents the germline stem cell. Gray 
circles around it represent cyst cell progenitor. Red circles 
represent spermatocytes in the stages of both mitosis and post-
mitotic growth. Blue circles correspond to spermatocytes in 
meiosis. Black circles and lines represent spermatids in post-
meiotic differentiation stages.  	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Figure 4-9. Eight-cell spermatocyte cysts were produced in the 
testis of Hfp mutants 
Testes from Drosophila adults of various genotypes were dissected 
and gently opened under pressure of a coverslip. Spermatocyte cysts 
were counted under phase contrast microscope. The percentage of 
cysts with various number of spermatocytes in each mutant testis 
are shown in graphs. In hfp13/hfp9 mutant testis more than half of 
the cysts contained 8 spermatocytes, while all the cysts in taf1 
RNAi testis contained 16 spermatocytes. The number of cysts counted 
(N) is indicated in each graph. Typical cyst phase contrast images 
are shown on the right side of the graphs. 	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Figure 4-10. The testis of Tra2 mutant flies contain cysts with 
normal numbers of spermatocyte 
Testes from two tra2 mutant genotypes were dissected and peeled 
open. Spermatocyte cysts were counted under phase contrast 
microscope. Percent of cysts with different number of spermatocytes 
in each mutant testis are shown in graphs. The number of 
spermatocytes in each cyst is normally 16, and no cyst with 
abnormal numbers of spermatocytes was observed. Total cysts counted 
for each genotype (N) are indicated. Phase contrast images of 
typical cysts are on the right side of the graphs. The Df(2R)Trix 
chromosome is indicated as Df(tra2). 	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5. Half Pint is required for normal spermatogenesis  
To further investigate how spermatogenesis is altered in Hfp 
mutants we examined the morphology of mature spermatids using, 
propidium iodide to stain DNA and antibodies against beta-tubulin, 
which is a major structural component of the spermatid tails. In 
wild type testes, as shown in figure 4-11, each cyst matures to 
form a bundle of aligned elongated spermatids with condensed nuclei.  
These accumulate primarily near the posterior end of testis 
(indicated with the arrow) where individualized mature sperm will 
eventually swim into the seminal vesicle. Prior to the completion 
of maturation, spermatid are nicely aligned with highly condensed 
needle like nuclei, identified with PI staining, and long tails 
identified by beta-tubulin staining (figure 4-11). However in Hfp 
mutants, clusters of aligned nuclei were not observed. Instead, the 
number of condensed nuclei is significantly diminished (figure 4-
11). Of the scattered nuclei observed, very few were elongated to 
form the needle-like shape formed in wild type. In addition the 
regular spatial relationship between nuclei and the tails found 
within normal cysts was lost. Based on beta-tubulin staining, tails 
appeared to be irregularly formed and nuclei were distributed 
within tails randomly (figure 4-11).   
To visualize individual cysts we tried squashing testes 
stained by anti beta-tubulin antibody and propidium iodide. As 
shown in figure 4-12, wild type testis showed nice alignment 
between spermatids that included both the nuclei and tails. But 
condensed nuclear bundles were not observed in Hfp mutant. Instead, 
large and irregularly shaped nuclei were scattered and no clear 
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connection was observed with tails. These observations suggest that 
during spermatid differentiation, the coordination development of 
spermatid heads and tails is impaired. 
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Figure 4-11. The differentiation of spermatid is impaired in both 
Hfp and Taf1 mutant testis  
Whole testis were dissected and stained with anti-beta tubulin 
antibody (green) and PI (red). Less sperm head bundles and tails 
were observed in both Hfp and Taf1 mutants. The magnified field 
from each image is indicated by the white square frame on the left. 
Few or no clusters of spermatid nuclei and fewer tails were seen in 
both Hfp and Taf1 mutants. Further, sperm nuclei were not found at 
the end of the cluster but rather were distributed throughout the 
cyst. The sperm nuclei showed irregular shaped instead of needle 
shaped in wild type.  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   169	  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Beta tubulin! Nucleus! Merge !
w1118!
hfp9/hfp13!
Bam-Gal4!
taf1 dsRNA! 	  	  	  
 
 
 
 
 
 
	   170	  
Figure 4-12. Hfp and Taf1 mutant males contain less sperm bundles 
and tails 
Immunostaining like in the previous figure is shown on spermatid 
cysts from squashed testes. Fewer recognizable nuclear bundles and 
tails were observed in both Hfp and Taf1 mutants. The magnified 
field from each image was indicated with white square frame on the 
left. Similar phenotypes with that in figure 4-11 were observed.  	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6. Hfp is required for correct meiosis during spermatogenesis 
The failure to produce normal mature spermatids could be due 
to aberrations in spermatid differentiation or to defects that 
occur in meiosis. To examine how these processes are affected by 
Hfp, we characterized cellular phenotypes of cysts at earlier 
stages.   
Examination of the testis as a whole showed that, in relation 
to wild type, Hfp mutant testis was in a relatively smaller size, 
which could be due to the observation that more than half of the 
cysts contained 8 spermatocytes instead of 16. Also Hfp mutants 
contained less sperm tails as indicated in wild type, which is 
consistent with the results of immunostaining assay, and suggests a 
relatively low number of mature spermatids (figure 4-13).  
After meiosis is completed, 64 spermatogonia are normally 
found in each cyst. The mitochondria in the cytoplasm of each cell 
aggregate and fuse with each other to form a structure called a 
Nebenkern, which is a dark spherical structure under phase contrast. 
In normal testes, a single Nebenkern is found closely associated 
with the cell nucleus and is about the same size, as shown in the 
w1118 cyst in figure 4-14. Changes in this arrangement are observed 
in Hfp mutants and are indicative of mistakes in meiosis. For 
example, we observed that Hfp mutant spermatids associated with 
multiple Nebenkern suggesting a failure in cytokinesis (figure 4-
14). In addition we found that nuclei of varying sizes were often 
found in postmeiotic cysts of Hfp mutants and that their size often 
differed substantially from that of the Nebenkern and from that of 
nuclei found in normal cysts at a similar stage. This variance in 
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size is an indication of chromosomal aneuploidy and suggests that 
the mutant cells fail to undergo normal chromosome segregation. 
Thus it is likely that Hfp mutants suffer from multiple defects in 
the process of meiosis in the male germline. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   173	  
w1118!
hfp9/hfp13!
Bam-Gal4!
taf1 dsRNA!
	  	  	  
Figure 4-13. Decreased amount of sperm tails developed within Hfp 
and Taf1 mutant testis 
Testes from one-day old male were dissected and images were taken 
with phase contrast microscope. Whole testis images were rebuilt 
with the same magnification scale. Genotypes are labeled on the 
left of the images. More white fibers are seen in wild type testis 
as indicated by the arrows. 	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Figure 4-14. Evidence of meiotic defects in Hfp and Taf1 mutant 
testes 
(A) Abnormal cytological phenotypes were observed in the onion 
stages of spermatid differentiation. Testes were dissected and 
squashed in the dissection buffer. Images were taken with phase 
contrast microscope. Nucleus are indicated with red arrows, and 
Nebenkern are indicated with blue arrows. Variably sized nuclei 
(white circles) were seen in both Hfp and Taf1 mutants, as 
indicated with red arrows. Multiple nucleus associated with one 
cytoplasm were also seen in both Hfp and Taf1 mutants as indicated 
with blue arrows. (B) In slightly later stages of spermatid 
differentiation Nebenkerns begin elongation as shown in the wild 
type control (w1118), but this abnormal in cysts from either Hfp or 
Taf1 mutants. In these cells Nebenkerns had irregular shapes and 
were associated with multiple small nuclei. 	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7. Comparative analysis of spermatogenesis phenotypes in Hfp, Tra2 
and Taf1 mutants  
 Analysis of splicing in Hfp and Tra2 mutants indicates that 
these factors have opposite effects on the regulation of taf1 exon 
12a splicing. Specifically, Hfp was observed to be required for 
normal levels of the exons inclusion which in turn leads to the 
expression of the testis-specific Taf1-2 protein isoform. If Taf1-2 
plays an important role in germ line development, we might expect 
that Taf1 loss-of-function genotypes would display phenotypes that 
overlap those of Hfp mutants. Interestingly it is reported that 8 
cell egg chambers, like those observed in Hfp females have been 
observed in the oogenesis of Taf1 mutants (Wassarman et al., 2000). 
But how the male germ cell development is affected by loss of Taf1 
has not been reported.  
To address this issue taf1-RNAi whole testis were examined by 
phase contrast, as seen in figure 4-13, Taf1 loss-of-function 
gonads was primarily filled with spermytocytes and relatively few 
mature spermatids are seen. This is consistent with the result from 
whole testis staining with anti beta-tubulin antibody. As shown in 
figure 4-11 and 4-12, few sperm tails were formed and almost no 
spermatid head bundles were seen in the whole testis of taf1-RNAi 
mutant. The phenotype is similar when squashed testis was stained. 
Spermatid tails are short, poor aligned with each other. Nuclei are 
relatively large and irregularly shaped in contrast to the needle-
shaped nuclei seen in wild type. Like in Hfp mutant spermatids were 
not well aligned and nuclei were observed to be distributed 
throughout the tails.  
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Under phase contrast, cytogenetic defects can be seen in the 
stages after meiosis (figure 4-14). Relatively large nuclei were 
seen in the stage of condensation. At the same time, uneven 
divisions produced many daughter nuclei with bigger and smaller 
sizes clustered within the same cyst. Some daughter nucleus shared 
the same Nebenkern, while some cells lost nucleus but has only 
Nebenkern left. However no 8-spermatocyte cysts was seen in taf1-
RNAi testes (figure 4-9). 
 These observations together suggest that Hfp and Taf1 mutants 
share some common phenotypes during spermatogenesis. And the 
phenotypes in taf1-RNAi mutant are more severe.  
 Unlike Hfp and Taf1, in both of two well studied Tra2 
genotypes tested, tra2B/tra21 and tra2B/Df(2R)Trix, only 16-
spermatocyte cyst was seen as shown in figure 4-10. Interestingly, 
this mutant also affects sperm nuclear morphology as described 
previously (Belote and Baker, 1983), but no effects on meiosis were 
observed in these testes. 
 
8. Meiosis-related markers are affected similarly in Hfp and 
Taf1 mutants 
 Since similar meiosis defects were observed in both Hfp and 
Taf1 mutant testis, we tested whether the molecular markers 
involved in meiosis were similarly affected by these two factors. 
The markers tested included the meiosis related genes always early 
(aly), cannonball (can), twine, cyclin A and cyclin B as well as 
the spermiogenesis-related genes don juan (dj) and fuzzy onions 
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(fzo). These particular markers were selected based on their 
previous characterization in studies on another meiosis-related 
gene mutant in the germline (Ayyar, 2003). Gene expression levels 
were examined by qRT-PCR in RNAs from taf1 RNAi and Hfp mutant 
testis. Mutations in the always early (aly) and cannonball (can) 
genes both produce meiosis-arrested phenotypes and these factors 
are thought to regulate transcription of target genes involved in 
entering meiosis. Expressions of cyclin A, cyclin B and twine are 
indicative of various steps related to meiosis initiation. Don Juan 
(dj) and fuzzy onions (fzo) are both genes required for the 
differentiation of functional sperm. As shown in figure 4-15, 
cyclin A and cyclin B were both significantly increased in Taf1 
mutant, similar but rather milder effects were seen in Hfp mutant. 
Twine has no statistically significant increase in both Hfp and 
Taf1 mutants, but its trend of changes are similar in the two 
mutants. Since cyclin A and twine RNA are both accumulated in late 
G2/M spermytocytes, the increase observed in their level is 
consistent with microscopic observations that these mutant testes 
have an increased proportion of pre-meiotic spermytocytes (figure 
4-13). Transcripts from dj were dramatically decreased in both Taf1 
and Hfp mutant. Since it was reported that dj is involved in the 
spermatid differentiation and maturation (Santel et al., 1998), its 
decreased level in both mutants is consistent with the staining 
result that sperm in both mutants showed developmental defects. 
However can was only down regulated in Hfp mutant. Cannonball is 
another testis-specific taf gene that is known to regulate 
downstream targets involved in meiosis (White-Cooper et al., 1998). 
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Its decreased level only observed in Hfp mutant suggests that Hfp 
might be in a higher position of the hierarchy of gene expression 
during spermatogenesis, but Taf1 is a downstream target. Other 
markers tested were not significantly affected in either mutant. 
This observation differs from that reported for mutations affecting 
genes encoding other germline specific Taf proteins which have more 
global effects on factors involved in meiosis and spermiogenesis 
(Ayyar, 2003; Hiller et al., 2004). 
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Figure 4-15. Expression levels of genes that are involved in 
meiosis in both Hfp and Taf1 mutant testis 
Gene expression levels of various marker genes are indicated as 
determined by qRT-PCR performed on RNA from dissected testes. All 
samples were normalized to parallel amplifications of the ribosomal 
protein L32 mRNA. Error bars represent the standard deviations of 
the means. 
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9. Examination of the fertility of Hfp mutant males affected 
by forced expression of Taf1  
If the phenotypic effects of Hfp on meiosis and spermiogenesis 
are due to it's effects on the expression of Taf1-2, then the 
forced expression of this product is expected to suppress (rescue) 
the sterility phenotypes of Hfp mutants. The taf1EP421 allele 
contains an EP element inserted in the first exon of Taf1. The EP 
element is a P element derived construct that contains UAS target 
sequences of Gal4 transcriptional factor at its 3' end. In the 
presence of GAL4, the gene downstream of the EP element will be 
transcribed in a tissue specific manner. To test whether a forced 
increase in Taf1 in spermatocytes results in rescue of the Hfp 
mutant phenotype we combined this EP element with the Bam-GAL4 
driver transgene in a Hfp mutant background. To build such a strain, 
a genetic recombination strategy was used to combine four elements 
within one genome: two Hfp mutant alleles, the Bam-Gal4 transgene 
and taf1EP421. The genetic scheme we used is shown in figure 4-16 and 
the increased taf1 expression level in the males produced was 
confirmed in results that are shown in figure 4-7.  
 The fertility of four element male flies were tested in 
crosses with wild type virgins. After mating, the genotypes of all 
male parents were verified by PCR (figure 4-17). Fertility test 
results are summarized in figure 4-18. The mean numbers of progeny 
in these crosses were 21.2 and 16.7 compared with Bam-Gal4; 
hfp9/hfp13. This suggests that increasing overall Taf1 transcription 
in this way had little, if any, effect on the fertility of Hfp 
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males. However we did note differences in the frequencies of males 
producing larger numbers of progeny. All wild type males tested 
produced more than 60 offspring, but individuals with this level of 
fecundity were not observed among Hfp mutants that carried Bam-Gal4. 
In contrast 8-15% of Hfp mutant males with Taf1 overexpression 
produced more than 60 offspring. This suggests that although the 
fertility of most mutant males is unaffected by increased Taf1 
expression, a small fraction of individuals has significantly 
increased fecundity. These observations warrant further 
investigation in the future as they may indicate an important role 
for the regulatory relationship between Hfp and Taf1 splicing.  
 
 
 
 
 
	   184	  
!"#$!"#$%&'()*&+,-./"01""
%&'(&)*++2%3&.+#$%&'()*&++,-./+")0+12/3+
4$5"#$*+++2%3&.+,-45/"67"6+
6+ !"#$!""8%+,-49/01"
!"#$*++2%3&./"#$%&'()*&+,-49/"01" 6+78+&)0&9&02"#:+ %&'(&)*+:;+,-45/"67"
;<=+++12+5"#$:+,>&?@A2?+BC3+D'A5+$"E@+#&)$+
4A'+@DFGH+")0+?"DGI;J7G+K+&0$)LDC+0A2.#$+FA:&L9$+#&)$:+
2%3&./"#$%&'()*&+,-45/"67"
-?AEM*+2%3&./"#$%&'()*&+,-49/"01"
A?@$'+5"#$:+D'A5++
0A2.#$+FA:&L9$++#&)$:++6+
9&'(&):+D'A5+?@$+:"5$++
0A2.#$+FA:&L9$+#&)$+
;"'?+N+
	  	  
!"#$%&&&!"#$%&'()*+,-+
'()*(+.++)/012/34%56+!"#$%5++,-./0&
1$2"#$&%&&&7*+890175*+:/012/341;#<(=6+5%5++3&
3& !"#$%&&&&5%>6+?"%&'(@*A:+
!"#$%&&)/012/34%>6+!"#$%&'(@*+A:+ 3&45&(+6(7(6."#8& '()*(+%&&BC%&'()*+,-+
9:;&&&-.&2"#$8&,<(=>?.=&@A0&B)?2&$"C>&#(+$&
B?)&D"2EF"#G&"+6&>BHI&J&(6$+KBA&6?.L#$&H?8(K7$&#(+$8&
)/012/34%>6+!"#$%&'()*+,-+
?=>$)&2"#$8&B)?2&&
6?.L#$&H?8(K7$&&#(+$8&&3&
7()*(+8&B)?2&=>$&8"2$&&
6?.L#$&H?8(K7$&#(+$&
M=?CN%&)/012/346+!"#$%&'()*+,-+
9")=&D&
	  
	   185	  
	  
!"#$"%&'!"#$%"&'()*+,-./01!2)34) (' )*+,&'*+,5627"+589':5./01;2)<=)
-%."/".0*+'1*+,'
'!"#$%"&'.>()*+,-.*+,562)7"+589':5)
(' !"#$"%&'?555@)
2,34'5,#6+"47'87'9:0%6%$':;3<#"%$3'
=*#4'>'
	  	  
!"#$"%&'!"#$%"&'()*+,-./(012!3+45+ (' )*+,&',-.67(012!3+45+
-*#.'/'
0%1"2"13*+'4*+,'
!"#$%"&'(8*+,-./(,-.67+
(' !"#$"%&'9666:+
-*#.'5'
!"#$"%&')()*+,-./(012!3+45+ (' )*+,&',-.67(012!3+45+
0%1"2"13*+'4*+,'
!"#$%"&'(8*+,-./(,-.67+
(' !"#$"%&'9666:+
	  
 
 
 
 
	   186	  
Figure 4-16. The schemes for fly crosses to generate strains with 
Taf1 overexpression in a Hfp mutant background 
The genetic scheme for producing the fly strain with both hfp13 and 
taf1EP421 is shown in part A. The production of the other fly strains 
with both hfp9 and Bam-Gal4 is shown in part B. The processes of 
producing other controls are shown in part C-E.  
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Figure 4-17. The verification of genotypes of recombined male flies 
Genotypes were tested with the primers specific to hfp, Bam-Gal4 
and EP421 by PCR. Genomic DNA was isolated from single male flies. 
Genotypes are indicated above the images. PCR products are labeled 
by the sizes and names. Both Hfp alleles contain a partially 
excised P element in the 5’ UTR. The insertion left behind the 
excision was about 80 nt in hfp13 mutant, and 480 nt in hfp9 mutant. 
The upstream primer used for amplifying hfp alleles is located 
upstream of the P element insertion site and the downstream one is 
within the hfp intron 1 (A). The PCR product of the wild type 
allele is less than 300 nt. No wild type allele was detected in the 
hfp9/hfp13 mutant genome (A,B). Primers internal to the Bam-Gal4 
element are used to detect it, as shown in (A) no signal of Bam-
Gal4 was detected in the wild type. Primers used for the EP421 
element are located at the boundary of the insertion site. The 
element was not detected in wild type genome as shown in (A). Lanes 
labeled “Gal” represent the Bam-Gal4 element, “EP” represent the 
EP421 element. 
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Figure 4-18. Fertility rescue test of Hfp mutant males by 
overexpressing Taf1 in testis 
Individual males flies from different genotypes were crossed with 
wild type virgins. Percent of tested males with different numbers 
of offspring are summarized in the graphs. Genotypes are shown 
above the graphs. The numbers of tested males are indicated (N). 
The mean number of progeny (M) are indicated. P values of each 
group are compared with the control genotype Bam-Gal4; hfp9/hfp13. 	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Discussion 
 
Although Hfp and Tra2 are both identified in the regulation of 
Taf1 exon 12a splicing, and some similar phenotypes are observed in 
mutants, one fundamental question is whether this alternative 
splicing event has any biological significance or is important for 
the normal spermatogenesis. As a transcriptional regulator, Taf1-2 
is highly enriched in Drosophila testis. Taf1 protein has two AT 
hook motifs, one is encoded in exon 12 and the other one is encoded 
in exon 12a. So only Taf1-2 and Taf1-4 contain both AT hook motifs 
in their final protein products. Previous studies have shown that 
both AT-hook motifs are required for Taf1 to bind to DNA target 
efficiently. Thus alternative splicing of exon 12a is predicted to 
directly affect the transcriptional activity of Taf1’s downstream 
targets, such as beta-tubulin, string and Don juan (Metcalf and 
Wassarman, 2006). By regulating exon 12a splicing, Hfp and Tra2 are 
potentially able to affect the binding activity and further the 
transcription function of Taf1. Therefore the regulation of exon 
12a inclusion influences the process of male germ cell development. 
The phenotypic similarities between Hfp and Taf1 mutants shown in 
our experiments suggest this prediction and the importance of Taf1-
2 alternative splicing during spermatogenesis. Additional 
experiment with Taf1-2 specifically expressed in the testis of Hfp 
mutant background would verify this idea. Partial rescue of the 
phenotypes in Hfp mutants would be expected by Taf1-2 
overexpression. 
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We discovered in Chapter 3 that Hfp and Tra2 together repress 
M1 intron splicing, but here the same two proteins regulate Taf1 
exon 12a splicing in opposite directions. Our in vivo experiments 
suggested that these factors act in in parallel pathways to affect 
Taf1. This conclusion is based on the observation that 
overexpressed Tra2 in vivo didn't result in more exon 12a skipping. 
Why might an increase in Tra2 affect exon 12a? Tra2 is known to be 
expressed at relatively high levels in the male germline (Mattox 
and Baker, 1991). As mentioned before, it is thought that tra2 uses 
a stronger promoter to reach high protein level in a short time and 
that negative feedback regulation is needed to limit these levels 
from becoming deleterious. So it is likely that Tra2 levels are not 
a limiting factor in promoting exon 12a skipping yet sharp 
reductions in Tra2, as can result in dramatic changes. So although 
Hfp is able to negatively regulate Tra2 through M1 splicing, this 
limitation in Tra2 levels has no impact on Taf1 splicing. Rather 
our results suggest that Hfp affects Taf1 splicing through a 
separate pathway.   
 
If exon 12a splicing is oppositely regulated by Tra2 and Hfp, 
it might be predicted that in Tra2 mutants, the number of 
spermytocytes in each cyst should be more than 16 or doubled to 32. 
It is reported that in Drosophila ovaries (Van Buskirk and 
Schupbach, 2002), Encore (enc) mutants contained 32-cell egg 
chambers, while Hfp mutants had 8-cell egg chambers. These two 
genes were thought to antagonize their functions in mitosis during 
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oogenesis through ovarian tumor’s (otu) activity. Especially Hfp 
was shown to regulate otu splicing in this process. Therefore it 
was thought that Otu was responsible for the mitotic cell division 
in oogenesis. However Otu is not thought to express in testis, 
therefore we hypothesized the regulation of taf1 splicing in testis 
would be responsible for the cell division during spermatogenesis. 
However, our results from two different tra2 mutants showed only 16 
spermatocyte cysts in the testes. That suggests that Tra2 probably 
plays limited roles on the mitotic division, or some other factors 
control mitosis are independent of Taf1 regulation.   
 
Genes participating in a common regulatory pathway often share 
similar phenotypes. We predicted that some overlap in phenotype 
between Hfp and Taf1 mutants would be expected if the regulation of 
Taf1-2 production is dependent on Hfp. The phenotypes observed from 
both Hfp mutant and taf1 RNAi knockdowns share a number of 
similarities which support the idea that these two proteins are in 
a common pathway that drives meiotic events and later 
spermatogenesis. Another striking similarity was observed between 
taf1 RNAi mutant and other reported TAF mutants, such as no hitter 
(nht) and meiosis I arrest (mia) (Ayyar, 2003; Hiller et al., 
2004). Taf1 was reported to function together with other testis 
specific Tafs and also co-localize with them in testis (Metcalf and 
Wassarman, 2007). Testes of Taf mutants consistently showed 
significant delays in meiosis and aberrations in spermiogenesis 
(Hiller et al., 2004; Hiller et al., 2001). Testes of these mutants 
are generally found filled with primary spermatocytes and a small 
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proportion of abnormal of later stages. The phenotypes we have 
observed in taf1 RNAi knockdowns is very similar to this suggesting 
that Taf1-2 could be one member of the germline TFIID complex and 
have an essential role on spermatogenesis.  
TFIID is a transcriptional complex containing TATA-box binding 
protein (TBP) and multiple TBP-associating factors (TAFs) 
(Matangkasombut et al., 2004). In Drosophila a common set of Tafs 
are generally expressed (Aoyagi and Wassarman, 2001), while there 
is another set of Tafs that are testis specific (Hiller et al., 
2004; Hiller et al., 2001; Metcalf and Wassarman, 2007). In general 
germ line and somatic Tafs are expressed from gene paralogs. 
However Taf1 is encoded by only one gene within the Drosophila 
genome (Wassarman et al., 2000). The expression of a germ line 
specific form of this protein (Taf1-2) is instead accomplished 
through alternative splicing. In our experiments, we showed that 
the testis-specific product of Taf1 is regulated by Hfp and Tra2. 
Exon 12a inclusion both causes Taf1-2 enrichment in testis, and 
also is critical for the normal development of the male germline. 
The phenotypic similarities between Hfp and Taf1 mutants were 
also supported by testing the molecular markers involved in 
meiosis. Both cyclin A and twine were shown increased in Hfp and 
Taf1 mutant testis. Cyclin A is a cell cycle related factor that 
reaches its highest level in primary spermytocytes and disappears 
abruptly before metaphase I. Its degradation is required for 
spermytocytes to continue meiosis (Lin et al., 1996). In our study, 
cyclin A mRNA is dramatically increased in taf1 mutant testis. This 
could be due to the up-regulation of one or more factors that drive 
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cyclin A expression in the taf1 mutant background. More likely it 
is because more primary spermytocytes accumulated in the testis and 
meiosis is significantly delayed. Twine is the Drosophila homologue 
of cdc25 in mammals and is specifically involved in meiosis in both 
the male and female germ line. Its mRNA first appears in early 
spermytocytes and further accumulates in primary spermytocytes. It 
is required for the initiation of the first meiotic division in 
testes (White-Cooper et al., 1998). Its protein level is more 
critical than its mRNA level for the meiosis initiation (White-
Cooper et al., 1998). In some Taf gene mutants, the testis where 
meiosis is blocked, Twine levels are observed to be decreased 
compared with that in wild type. In the Hfp and Taf1 mutant testis, 
the level of Twine level is not decreased which is consistent with 
the observation that meiosis does happen in these two mutants even 
though the process is impaired as shown in figure 4-14. The dj gene 
is required for the formation of spermatid and mature sperm and 
also implicated in normal Nebenkern formation (Santel et al., 
1998). In vitro studies have shown that dj could be a potential 
transcriptional target of Taf1 (Metcalf and Wassarman, 2006). Its 
decrease in both of Hfp and Taf1 mutant testis is consistent with 
our testis staining result that abnormal Nebenkern were formed and 
failed elongated sperm head were seen. Also this result supports 
the idea that Hfp regulates spermatogenesis partially through 
regulating the splicing of taf1 exon12a. 
 
Another interesting question is how Hfp can help Tra2 repress 
M1 splicing but promote exon 12a splicing? What differences might 
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exist in these substrate sequences that would be responsible for 
the different behaviors of the same splicing factors?  Exon 12a has 
a weak 3’ splice site in the upstream intron. It also contains two 
CAAGR elements like those found in the ISS of the M1 intron as well 
as a CACAGG that resembles the binding site of Tra2 in dsx 
enhancer. These three elements are very close to the 3’ splice site 
upstream of exon 12a and may participate in exon skipping. Studies 
in mammalian cells showed that the Hfp homolog, PUF60, could 
recognize weak 3’ splice sites and promote RNA splicing (Page-McCaw 
et al., 1999; Valcarcel et al., 2007). Also evaluations of the 
splice site strength in Taf1 pre-mRNA showed that exon 12a 
contained a moderate 3’ splice site while the 3’ splice site in 
exon 13 was even weaker. Hfp could function in both of the 3’ 
splice sites and help exon 12a inclusion. However we don’t have 
information of Hfp binding specificity, it is still not clear how 
Hfp can promote exon12a splicing. 
 
Alternative splicing is a process that is extensively observed 
within the transcriptome. Most genes are encoded by multiple exons 
and their mRNAs are alternatively spliced (Wang et al., 2008). With 
variation in developmental stage or conditions, many alternative 
splicing events can be observed switched more or less in either 
direction. Many splicing changes have been reported in fly mutants 
and RNAi-treated cells. However, little is know that within these 
splicing changes, which one has a significant consequence and which 
are simply indirect noisy effect of other factors. In our study, we 
discovered that a small exon of Taf1 can be regulated by two 
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splicing factors and this splicing event probably is important for 
normal meiosis of germ cell development in fly testis.    
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Summation And Future Directions 
M1 intron retention mediated by Tra2 is only seen in 
Drosophila male germ line. However, this regulation occurs in 
response to high transcriptional levels of Tra2 in the germline 
rather than to a tissue specific factor (Mattox and Baker, 1991; Qi 
et al., 2006). Therefore, although this regulation is tissue 
specific in vivo, many cell types retain the competence to exert M1 
repression and it has been observed that M1 retention can be 
induced in either somatic tissues or cultured cells by elevating 
Tra2 level (Qi et al., 2006). We took advantage of this by using 
splicing reporters in a Drosophila S2 cell based RNAi screen to 
identify Hfp/Puf68 as a participant in the splicing repression of 
M1 intron both in cultured cells and in vivo. Both Tra2 and Hfp 
were regarded as splicing activators based on studies of other 
substrates (Inoue et al., 1992; Ryner and Baker, 1991; Van Buskirk 
and Schupbach, 2002). However they both displayed negative 
regulatory function on M1 intron splicing (Chandler et al., 2003; 
Mattox and Baker, 1991; Qi et al., 2007). More interestingly, both 
of these factors themselves have multiple protein isoforms but 
different behaviors were observed for their effects on M1 splicing 
(Mattox et al., 1996; Mattox et al., 1990). We found Hfp had two 
isoforms that differ from each other in the N terminus containing 
four serine-arginine dipeptides. The two isoforms were verified in 
vivo, and their functional differences in S2 cells may be due to 
the distinct patterns of subcellular localization. It will be 
interesting to know whether similar distribution patterns are also 
	   199	  
present in tissues. Besides the localized distribution, a more 
important question for these two isoforms is whether there are any 
other functional differences between them. Does Hfp58 have the same 
effect on the regulation of c-myc transcription as Hfp68 does? Does 
Hfp58 also have a splicing function that is relevant in other RNA 
substrates? If so, does Hfp58 display a positive regulatory role in 
splicing? Like Tra2 that is predicted to have three kinds of 
protein isoforms, the functions that each isoform of Hfp takes can 
be tested by introducing them individually into Hfp mutant 
background.  
 
 Curiously, the regulators identified so far to be involved in 
repression of M1 intron splicing are all known to act as splicing 
activators in other contexts. Tra2 and Rbp1 both promote female 
specific splicing of both dsx pre-mRNA and fruitless pre-mRNA 
(Heinrichs and Baker, 1995; Heinrichs et al., 1998; Ryner and 
Baker, 1991). Hfp favors exon inclusion in the alternative splicing 
of Otu pre-mRNA in Drosophila oocytes (Van Buskirk and Schupbach, 
2002). Yet our findings here implicate Tra2 and Hfp as co-
repressors of M1 and Rbp1 was shown to be able to repress M1 
splicing both in living S2 cells (Kumar and Lopez, 2005) and 
nuclear extracts (Qi et al., 2007) in previous studies, even though 
it showed minor activation activity in our reporter based screen. A 
challenging question for the regulation of alternative splicing 
therefore is how these splicing activators function together to 
repress RNA splicing of M1 intron? It has been shown that Tra2 
could repress M1 splicing through the CAAGR repeats of ISS element 
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in vitro and Rbp1 functions independently through a small fragment 
outside of the repeats in the ISS. In our studies, we found the 
negative regulatory function of Hfp requires both the ISS and a 
weak 3’ splice site in the intron. The phenomenon of position-
dependent regulation of alternative splicing has been reported in 
several splicing factors. Their regulatory roles on RNA splicing 
depend on where they bind, upstream or downstream of the regulated 
exons. Similarly Tra2 and other SR factors exert position dependent 
effects on alternative splicing as discussed in Chapter One. Upon 
binding to exons these factors help to promote exon inclusion but 
repress splicing when they are bound to introns. Notably each of 
the factors implicated in M1 repression, act through sequences 
located within the intron. However a detailed explanation of the 
mechanism of splicing repression by SR factors has yet to be 
defined. Why these factors could not just promote recognition of a 
weak 3’ splice site by binding to the nearby intronic elements is 
unclear. Exon definition by an SR protein-containing complex offers 
one potential explanation. Based on the result of our study we 
speculate that Hfp represses splicing by potentially competing with 
the activity of U2AF50 within the 3’ region of the M1 intron and 
form another more stable complex across the whole M1 intron with 
Tra2 that binds to the ISS. Eventually this big complex could 
communicate with complexes formed in the flanking exons and define 
the entire exon3-M1-Exon4 fragment as a single exon. This model not 
only can explain the phenomenon of SR-mediated splicing repression, 
but also is consistent with the observed differences in the effect 
of exon verses intron bound SR factors. Usually a weak splice site 
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is required for the regulation of alternative splicing and Hfp’s 
vertebrate orthologue PUF60 has been specifically associated with 
recognition of weak 3’ splice sites. That could be the reason why 
Hfp is required for M1 retention and why a strong 3’ splice site 
could abolish M1 repression in vivo. Consistent with this I 
observed that when the dsx enhancer, which contains strong binding 
element for Tra2 was inserted into ftz intron containing a strong 
3’ splice site, it still could not mediate intron repression even 
in the presence of elevated Tra2 level in S2 cells (data not 
shown). To further test the above model, an intron with strong 3’ 
splice site could be included upstream of exon 3 and an intron with 
strong 5’ splice site could be included downstream of exon 4. When 
the transcript is expressed in S2 cells, Tra2 would be predicted 
cause the whole exon3-M1-exon4 to be included with upstream and 
downstream exons in the final mRNA.  
 
 Alternative splicing of Taf1 exon 12a was found in our study 
to be regulated oppositely by Tra2 and Hfp in Drosophila testis. 
Because exon 12a encodes another AT hook of Taf1 protein, its 
splicing could potentially influence the transcriptional activity 
of Taf1 (Metcalf and Wassarman, 2006). Further spermatogenesis in 
both Hfp and Taf1 mutants were examined and similar effects between 
the two mutants were recorded. These observations suggest that the 
regulation of male germ cell development by Hfp is partially 
through the regulation of taf1 alternative splicing. From our 
rescue experiment, minor effect was seen by forced expression of 
Taf1 in the Hfp mutant background. To further confirm the 
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regulation of Hfp on Taf1 splicing, Taf1-2 isoform, the testis-
enriched isoform with exon12a inclusion, should be specifically 
expressed in testis in the Hfp mutant background. This raises the 
question of how Hfp plays opposite roles of Tra2 on the exon 12a 
splicing. What elements within these introns or exons are required 
for Hfp activation but also suffice for Tra2 repression? At present 
we do not know if Hfp or Tra2 directly associates with taf1 
transcript. By comparison with the situation in the M1 intron, the 
mechanism of exon 12a splicing regulation by both Hfp and Tra2 
could provide deeper understanding of the regulatory roles of 
splicing factors in different contexts.   
 
 The splicing regulations of both M1 intron and Taf1 exon 12a 
are both involved in the male germline development. Germ cell 
development and differentiation is one of the most complex 
processes in multi-cell organisms that alternative splicing is 
known to play important roles in (Elliott, 2004; Walker et al., 
1999). By studying splicing regulation, we can understand how 
tissue-specific isoforms are produced and how their alternative 
splicing is employed by such tissues to produce special functions, 
not only for normal germ cell growth and differentiation but also 
for the abnormal incidence of certain types of cancers.  
 
 The mechanism of splicing regulation in molecular level is not 
only an interesting topic but also critical to understand the 
pathology of certain diseases and further provide therapeutic 
choices in clinic. Recently a very promising treatment for spinal 
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muscular atrophy was developed by correcting the abnormal splicing 
of SMN-2 pre-mRNA with antisense oligonucleotides in mouse (Hua et 
al., 2010). More successful cases will be reported to cure diseases 
if the mechanisms of alternative splicing are better understood in 
the future. 	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